Papers

Papers

TitleAuthorsCitationJournal/BookPublication YearLink
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile InfectionGoren I, Fallek Boldes O, Boldes T, Knyazev O, Kagramanova A, Limdi JK, Liu E, Sethi-Arora K, Holvoet T, Eder P, Bezzio C, Saibeni S, Vernero M, Alimenti E, Chaparro M, Gisbert JP, Orfanoudaki E, Koutroubakis IE, Pugliese D, Cuccia G, Calviño Suarez C, Ribaldone DG, Veisman I, Sharif K, Aratari A, Papi C, Mylonas I, Mantzaris GJ, Truyens M, Lobaton T, Nancey S, Castiglione F, Nardone OM, Calabrese G, Karmiris K, Velegraki M, Theodoropoulou A, Shitrit AB, Lukas M, Vojtechová G, Ellul P, Bugeja L, Savarino EV, Fischler TS, Dotan I, Yanai H.J Crohns Colitis. 2024 Oct 21:jjae161. doi: 10.1093/ecco-jcc/jjae161. Online ahead of print.J Crohns Colitis2024Link
Low-Grade Activation of the Extrinsic Coagulation Pathway in Patients with Ulcerative ColitisDrygiannakis I, Valatas V, Filidou E, Tzenaki N, Archontoulaki E, Dovrolis N, Kandilogiannakis L, Kefalogiannis G, Sidiropoulos P, Kolios G, Koutroubakis IE.Dig Dis Sci. 2024 Oct;69(10):3773-3785. doi: 10.1007/s10620-024-08640-1. Epub 2024 Sep 25.Dig Dis Sci2024Link
Intestinal Stromal Cells in the Turmoil of Inflammation and Defective Connective Tissue Remodeling in Inflammatory Bowel DiseaseDrygiannakis I, Kolios G, Filidou E, Bamias G, Valatas V.Inflamm Bowel Dis. 2024 Sep 3;30(9):1604-1618. doi: 10.1093/ibd/izae066.Inflamm Bowel Dis2024Link
Prophylactic Versus Endoscopy-driven Treatment of Crohn's Postoperative Recurrence: A Retrospective, Multicentric, European Study [PORCSE Study]Geldof J, Truyens M, Hanssens M, Van Gucht E, Holvoet T, Elorza A, Bouillon V, Barros S, Martins V, Argyriou K, Potamianos S, Diculescu M, Stroie T, Bossuyt P, Moens A, Theodoraki E, Koutroubakis IE, Pedro J, Fernandes S, Nikolaou P, Karmiris K, Baert FJ, Ferreiro-Iglesias R, Peeters H, Claeys S, Casanova MJ, Eder P, Porter RJ, Arnott I, Karakan T, Mesonero F, Revés J, Van Dyck E, Jauregui-Amezaga A, Mañosa M, Rivière P, Marquez Mosquera L, Portela F, Pimentel R, Lobaton T.J Crohns Colitis. 2024 Aug 14;18(8):1202-1214. doi: 10.1093/ecco-jcc/jjae011.J Crohns Colitis2024Link
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational StudyDragoni G, Innocenti T, Amiot A, Castiglione F, Melotti L, Festa S, Savarino EV, Truyens M, Argyriou K, Noviello D, Molnar T, Bouillon V, Bezzio C, Eder P, Fernandes S, Kagramanova A, Armuzzi A, Oliveira R, Viola A, Ribaldone DG, Drygiannakis I, Viganò C, Calella F, Gravina AG, Pugliese D, Chaparro M, Ellul P, Vieujean S, Milla M, Caprioli F; “TOFA-poSTOP” Study Group.Am J Gastroenterol. 2024 Aug 1;119(8):1525-1535. doi: 10.14309/ajg.0000000000002676. Epub 2024 Feb 2.Am J Gastroenterol2024Link
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortiumLenti MV, Ribaldone DG, Borrelli de Andreis F, Vernero M, Barberio B, De Ruvo M, Savarino EV, Kav T, Blesl A, Franzoi M, Gröchenig HP, Pugliese D, Ianiro G, Porcari S, Cammarota G, Gasbarrini A, Spagnuolo R, Ellul P, Foteinogiannopoulou K, Koutroubakis I, Argyriou K, Cappello M, Jauregui-Amezaga A, Demarzo MG, Silvestris N, Armuzzi A, Sottotetti F, Bertani L, Festa S, Eder P, Pedrazzoli P, Lasagna A, Vanoli A, Gambini G, Santacroce G, Rossi CM, Delliponti M, Klersy C, Corazza GR, Di Sabatino A; European Consortium for the study of immune checkpoint inhibitor-induced colitis.ESMO Open. 2024 Jul;9(7):103632. doi: 10.1016/j.esmoop.2024.103632. Epub 2024 Jul 5.ESMO Open2024Link
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international studyAllocca M, Catalano G, Savarino EV, Chaparro M, Levartovsky A, Michalopoulos G, Viazis N, Fousekis FS, Psistakis A, Noviello D, Nascimento CND, Caron B, Kitsou V, Bamias G, García MJ, Zacharopoulou E, Foteinogiannopoulou K, D'Amico F, Koutroubakis I, Ellul P, Tzouvala M, Peyrin-Biroulet L, Torres J, Caprioli F, Karmiris K, Theodoropoulou A, Katsanos KH, Christodoulou DK, Mantzaris GJ, Kopylov U, Gisbert JP, Danese S, Magro F, Carla F, Fiorino G.United European Gastroenterol J. 2024 Jun;12(5):543-551. doi: 10.1002/ueg2.12492. Epub 2024 Feb 28.United European Gastroenterol J2024Link
Iron therapy supplementation in inflammatory bowel disease patients with iron deficiency anemia: findings from a real-world analysis in ItalyFiorino G, Colombel JF, Katsanos K, Mearin F, Stein J, Andretta M, Antonacci S, Arenare L, Citraro R, Dell'Orco S, Degli Esposti L, Ramirez de Arellano Serna A, Morin NT, Koutroubakis IE.Eur J Gastroenterol Hepatol. 2024 May 1;36(5):563-570. doi: 10.1097/MEG.0000000000002740. Epub 2024 Mar 1.Eur J Gastroenterol Hepatol2024Link
Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBDVieujean S, Lindsay JO, D'Amico F, Ahuja V, Silverberg MS, Sood A, Yamamoto-Furusho JK, Nagahori M, Watanabe M, Koutroubakis IE, Foteinogiannopoulou K, Avni Biron I, Walsh A, Outtier A, Nordestgaard RLM, Abreu MT, Dubinsky M, Siegel C, Louis E, Dotan I, Reinisch W, Danese S, Rubin DT, Peyrin-Biroulet L.J Crohns Colitis. 2024 Apr 23;18(4):548-559. doi: 10.1093/ecco-jcc/jjad180.J Crohns Colitis2024Link
Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective StudyKalaitzakis ZE, Giahnakis E, Koutroubakis IE, Mouzas IA, Kalaitzakis E.Dig Dis Sci. 2024 Apr;69(4):1467-1478. doi: 10.1007/s10620-023-08223-6. Epub 2024 Feb 27.Dig Dis Sci2024Link
Total and individual PBC-40 scores are reliable for the assessment of health-related quality of life in Greek patients with primary biliary cholangitisI Rigopoulou E, Bakarozi M, Dimas I, Galanis K, Lygoura V, K Gatselis N, Koulentaki M, N Dalekos G.J Transl Int Med. 2023 Sep 2;11(3):246-254. doi: 10.2478/jtim-2023-0098. eCollection 2023 Sep.J Transl Int Med2023Link
HERACLIS-HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg-positive patientsPapatheodoridis G, Mimidis K, Manolakopoulos S, Triantos C, Vlachogiannakos I, Veretanos C, Deutsch M, Karatapanis S, Goulis I, Elefsiniotis I, Cholongitas E, Sevastianos V, Christodoulou D, Samonakis D, Manesis E, Kapatais A, Papadopoulos N, Ioannidou P, Germanidis G, Giannoulis G, Lakiotaki D, Kogias D, Kranidioti Η, Zisimopoulos K, Mela M, Kontos G, Fytili P, Manolaka C, Agorastou P, Pantzios SI, Papatheodoridi M, Karagiannakis D, Geladari E, Psychos N, Zachou K, Chalkidou A, Spanoudaki A, Thomopoulos K, Dalekos G.Liver Int. 2023 Sep;43(9):1879-1889. doi: 10.1111/liv.15638. Epub 2023 Jun 8.Liver Int2023Link
Lymphogranuloma venereum and CMV co-infection mimicking ulcerative proctitis in a non-immunocompromised patientTsafaridou M, Augoustaki A, Koutroubakis I.Eur J Gastroenterol Hepatol. 2023 Aug 1;35(8):921-922. doi: 10.1097/MEG.0000000000002580. Epub 2023 Jun 28.Eur J Gastroenterol Hepatol2023Link
Etiology of Anemia and Risk Factors of Mortality among Hospitalized Patients: A Real-Life Retrospective Study in a Tertiary Center in GreeceIoannou P, Papazachariou A, Tsafaridou M, Koutroubakis IE, Kofteridis DP.Hematol Rep. 2023 Jun 2;15(2):347-357. doi: 10.3390/hematolrep15020036.Hematol Rep2023Link
Iron deficiency anemia impacts disease progression and healthcare resource consumption in patients with inflammatory bowel disease: a real-world evidence studyFiorino G, Colombel JF, Katsanos K, Mearin F, Stein J, Andretta M, Antonacci S, Arenare L, Citraro R, Dell'Orco S, Degli Esposti L, Ramirez de Arellano Serna A, Morin N, Koutroubakis IE.Therap Adv Gastroenterol. 2023 May 30;16:17562848231177153. doi: 10.1177/17562848231177153. eCollection 2023.Therap Adv Gastroenterol2023Link
The Inflammatory Bowel Disease-Disk Tool for Assessing Disability in Inflammatory Bowel Disease Patients: Validation of the Greek VersionKatsoula A, Axiaris G, Mpitouli A, Palatianou M, Christidou A, Dimitriadis N, Nakos A, Pastras P, Kourkoulis P, Karatzas P, Moutzoukis M, Zlatinoudis C, Philippidis A, Kourikou A, Kokkotis G, Gklavas A, Machaira A, Mantaka A, Talimtzi P, Anagnostopoulou E, Koutroubakis IE, Papaconstantinou I, Bamias G, Manolakopoulos S, Mathou N, Paraskeva K, Protopappas A, Tsironi E, Katsanos KH, Christodoulou DK, Papatheodoridis G, Michalopoulos G, Theocharis G, Triantos C, Pachiadakis I, Soufleris K, Viazis N, Mantzaris GJ, Tribonias G, Tzouvala M, Theodoropoulou A, Karmiris K, Zampeli E, Michopoulos S, Haidich AB, Giouleme O.J Clin Med. 2023 Apr 21;12(8):3023. doi: 10.3390/jcm12083023.J Clin Med2023Link
Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel DiseaseOrfanoudaki E, Foteinogiannopoulou K, Theodoraki E, Koutroubakis IE.J Clin Med. 2023 Mar 23;12(7):2452. doi: 10.3390/jcm12072452.J Clin Med2023Link
Treatment of portal vein thrombosis in cirrhosis: a multicenter real life cοhort studyMantaka A, Gatselis N, Triantos CK, Thalheimer U, Leandro G, Zachou K, Konstantakis C, Saitis A, Thomopoulos K, Kouroumalis EA, Dalekos GN, Samonakis DN.Minerva Gastroenterol (Torino). 2023 Mar;69(1):107-113. doi: 10.23736/S2724-5985.21.02861-8.Minerva Gastroenterol (Torino)2023Link
The natural history of COVID-19 in vaccinated inflammatory bowel disease patientsViazis N, Drygiannakis I, Karmiris K, Theodoropoulou A, Zampeli E, Tzouvala M, Bamias G, Liatsos C, Theocharis G, Vrakas S, Tsironi E, Mathou N, Mantaka A, Christidou A, Koustenis K, Veretanos C, Papathanasiou E, Zacharopoulou E, Tribonias G, Kitsou V, Kartsoli S, Theodoulou A, Michopoulos S, Thomopoulos K, Koutroubakis IE, Mantzaris GJ.Dig Liver Dis. 2023 Mar;55(3):305-309. doi: 10.1016/j.dld.2022.12.012. Epub 2023 Jan 17.Dig Liver Dis2023Link
Editorial: Stromal and immune cell interactions in intestinal inflammation and fibrosisValatas V, Kitamura K, Ward SG, Kolios G.Front Immunol. 2023 Feb 16;14:1152140. doi: 10.3389/fimmu.2023.1152140. eCollection 2023.Front Immunol2023Link
Crohn's Disease-Like Features in a Patient With IgE and Selective IgG1 and IgG3 DeficiencyDrygiannakis I, Theodoraki E, Tsafaridou M, Koutroubakis I.Cureus. 2023 Feb 5;15(2):e34655. doi: 10.7759/cureus.34655. eCollection 2023 Feb.Cureus2023Link
Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic RegistryZacharopoulou E, Orfanoudaki E, Tzouvala M, Tribonias G, Kokkotis G, Kitsou V, Almpani F, Christidou A, Viazis N, Mantzaris GJ, Tsafaridou M, Karmiris K, Theodoropoulou A, Papathanasiou E, Zampeli E, Michopoulos S, Tigkas S, Michalopoulos G, Laoudi E, Karatzas P, Mylonas I, Kyriakos N, Liatsos C, Kafetzi T, Theocharis G, Taka S, Panagiotopoulou K, Koutroubakis IE, Bamias G.Inflamm Bowel Dis. 2023 Feb 1;29(2):228-237. doi: 10.1093/ibd/izac068.Inflamm Bowel Dis2023Link
Active smoking is associated with the development of adverse events of biological therapy in patients with inflammatory bowel diseaseTheodoraki E, Orfanoudaki E, Petroulaki E, Foteinogiannopoulou K, Koutroubakis IE.Eur J Gastroenterol Hepatol. 2023 Jan 1;35(1):15-20. doi: 10.1097/MEG.0000000000002445. Epub 2022 Sep 12.Eur J Gastroenterol Hepatol2023Link
Co-expression of fibrotic genes in inflammatory bowel disease; A localized event?Dovrolis N, Filidou E, Tarapatzi G, Kokkotis G, Spathakis M, Kandilogiannakis L, Drygiannakis I, Valatas V, Arvanitidis K, Karakasiliotis I, Vradelis S, Manolopoulos VG, Paspaliaris V, Bamias G, Kolios G.Front Immunol. 2022 Dec 23;13:1058237. doi: 10.3389/fimmu.2022.1058237. eCollection 2022.Front Immunol2022Link
Enzymes of Fibrosis in Chronic Liver DiseaseTsomidis I, Notas G, Xidakis C, Voumvouraki A, Samonakis DN, Koulentaki M, Kouroumalis E.Biomedicines. 2022 Dec 8;10(12):3179. doi: 10.3390/biomedicines10123179.Biomedicines2022Link
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European StudyYanai H, Kagramanova A, Knyazev O, Sabino J, Haenen S, Mantzaris GJ, Mountaki K, Armuzzi A, Pugliese D, Furfaro F, Fiorino G, Drobne D, Kurent T, Yassin S, Maharshak N, Castiglione F, de Sire R, Nardone OM, Farkas K, Molnar T, Krznaric Z, Brinar M, Chashkova E, Livne Margolin M, Kopylov U, Bezzio C, Bar-Gil Shitrit A, Lukas M, Chaparro M, Truyens M, Nancey S, Lobaton T, Gisbert JP, Saibeni S, Bacsúr P, Bossuyt P, Schulberg J, Hoentjen F, Viganò C, Palermo A, Torres J, Revés J, Karmiris K, Velegraki M, Savarino E, Markopoulos P, Tsironi E, Ellul P, Calviño Suárez C, Weisshof R, Ben-Hur D, Naftali T, Eriksson C, Koutroubakis IE, Foteinogiannopoulou K, Limdi JK, Liu E, Surís G, Calabrese E, Zorzi F, Filip R, Ribaldone DG, Snir Y, Goren I, Banai-Eran H, Broytman Y, Amir Barak H, Avni-Biron I, Ollech JE, Dotan I, Aharoni Golan M.J Crohns Colitis. 2022 Dec 5;16(12):1882-1892. doi: 10.1093/ecco-jcc/jjac100.J Crohns Colitis2022Link
IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL ConsensusCaron B, Abreu MT, Siegel CA, Panaccione R, Sands BE, Dignass A, Turner D, Dotan I, Hart AL, Ahuja V, Allez M, Ananthakrishnan AN, Ghosh S, Griffiths AM, Halfvarson J, Kaser A, Kotze PG, Koutroubakis IE, Lakatos PL, Levine A, Lewis JD, Magro F, Mantzaris GJ, O'Morain C, Ran Z, Reinisch W, Rogler G, Sachar DB, Siegmund B, Silverberg MS, Sood A, Spinelli A, Steinwurz F, Tysk C, Yamamoto-Furusho JK, Schreiber S, Rubin DT, Sandborn WJ, Danese S, Peyrin-Biroulet L.Clin Gastroenterol Hepatol. 2022 Nov;20(11):2619-2627.e1. doi: 10.1016/j.cgh.2022.02.032. Epub 2022 Feb 19.Clin Gastroenterol Hepatol2022Link
The Probiotic Strains Bifidοbacterium lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Saccharomyces boulardii Regulate Wound Healing and Chemokine Responses in Human Intestinal Subepithelial MyofibroblastsTarapatzi G, Filidou E, Kandilogiannakis L, Spathakis M, Gaitanidou M, Arvanitidis K, Drygiannakis I, Valatas V, Kotzampassi K, Manolopoulos VG, Kolios G, Vradelis S.Pharmaceuticals (Basel). 2022 Oct 20;15(10):1293. doi: 10.3390/ph15101293.Pharmaceuticals (Basel)2022Link
High Hereditary Transthyretin-Related Amyloidosis Prevalence in Crete: Genetic Heterogeneity and Distinct PhenotypesTzagournissakis M, Foukarakis E, Samonakis D, Tsilimbaris M, Michaelidou K, Mathioudakis L, Marinis A, Giannakoudakis E, Spanaki C, Skoula I, Erimaki S, Amoiridis G, Koutsis G, Koukouraki S, Stylianou K, Plaitakis A, Mitsias PD, Zaganas I.Neurol Genet. 2022 Sep 9;8(5):e200013. doi: 10.1212/NXG.0000000000200013. eCollection 2022 Oct.Neurol Genet2022Link
Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use protect from chronic inflammation-induced atherosclerosis?Mantaka A, Galanakis N, Tsetis D, Koutroubakis IE.Intest Res. 2022 Oct;20(4):495-505. doi: 10.5217/ir.2022.00017. Epub 2022 Aug 8.Intest Res2022Link
Buried Bumper Syndrome is not caused by levodopa infusion. Reply to Dr Kotzampassi's Letter to the Editor. Concerning the publication: Buried Bumper Syndrome: A common complication of levodopa intestinal infusion for Parkinson disease. By: Spanaki C, Boura I, Avgoustaki A, Orfanoudaki E, Giannopoulou IA, Giakoumakis E, Chlouverakis G, Athanasakis E, Koulentaki M. Parkinsonism Relat Disord. 2021 Apr; 85:59-62Spanaki C, Boura I, Orfanoudaki E, Avgoustaki A, Athanasakis E, Koulentaki M.Parkinsonism Relat Disord. 2022 Sep;102:121. doi: 10.1016/j.parkreldis.2022.04.010. Epub 2022 Apr 25.Parkinsonism Relat Disord2022Link
Mental Health, Work Presenteeism, and Exercise in Inflammatory Bowel DiseaseSciberras M, Karmiris K, Nascimento C, Tabone T, Nikolaou P, Theodoropoulou A, Mula A, Goren I, Yanai H, Amir H, Mantzaris GJ, Georgiadi T, Foteinogiannopoulou K, Koutroubakis I, Allocca M, Fiorino G, Furfaro F, Katsanos K, Fousekis F, Michalopoulos G, Camilleri L, Torres J, Ellul P.J Crohns Colitis. 2022 Aug 30;16(8):1197-1201. doi: 10.1093/ecco-jcc/jjac037.J Crohns Colitis2022Link
Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based SurveyEllul P, Revés J, Abreu B, Chaparro M, Gisbert JP, Allocca M, Fiorino G, Barberio B, Zingone F, Pisani A, Cassar D, Michalopoulos G, Mantzaris G, Koutroubakis I, Karmiris K, Katsanos K, Ďuricova D, Burisch J, Madsen GR, Maaser C, Naila A, Orfanoudaki E, Milivojevic V, Buisson A, Avedano L, Leone S, Torres J.J Crohns Colitis. 2022 Aug 4;16(7):1070-1078. doi: 10.1093/ecco-jcc/jjac010.J Crohns Colitis2022Link
HERACLIS-TAF: a multi-centre prospective cohort study on 2-year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risksPapatheodoridis GV, Mimidis K, Manolakopoulos S, Gatselis N, Goulis J, Kapatais A, Manesis E, Vasiliadis T, Triantos C, Samonakis D, Sevastianos V, Karatapanis S, Elefsiniotis I, Deutsch M, Mylopoulou T, Papatheodoridi M, Kranidioti H, Agorastou P, Karaoulani T, Kyriazidou A, Zisimopoulos K, Dalekos GN.Aliment Pharmacol Ther. 2022 Aug;56(4):702-712. doi: 10.1111/apt.17093. Epub 2022 Jun 23.Aliment Pharmacol Ther2022Link
Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case SeriesFesta S, Zerboni G, Derikx LAAP, Ribaldone DG, Dragoni G, Buskens C, van Dijkum EN, Pugliese D, Panzuto F, Krela-Kaźmierczak I, Mintz HR, Shitrit AB, Chaparro M, Gisbert JP, Kopylov U, Teich N, Vainer E, Nagtegaal I, Hoentjen F, Garcia MJ, Filip R, Foteinogiannopoulou K, Koutroubakis IE, Argollo M, van Wanrooij RLJ, Laja H, Lobaton T, Truyens M, Molnar T, Savarino E, Aratari A, Papi C, Goren I.J Crohns Colitis. 2022 Jul 14;16(6):940-945. doi: 10.1093/ecco-jcc/jjab217.J Crohns Colitis2022Link
Coagulation disorders and vascular diseases of the liver in patients with COVID-19Tsafaridou M, Maniadaki I, Koutroubakis I, Samonakis DN.Clin Exp Hepatol. 2022 Jun;8(2):97-102. doi: 10.5114/ceh.2022.116972. Epub 2022 Jun 14.Clin Exp Hepatol2022Link
Nutritional Assessment of Greek Liver Cirrhosis Patients: Mini Nutritional Assessment Predicts MortalityKoulentaki M, Drygiannakis I, Mantaka A, Moschapidakis E, Chalkiadaki A, Augoustaki A, Spyridaki A, Kouroumalis E, Markaki A.Healthcare (Basel). 2022 May 6;10(5):859. doi: 10.3390/healthcare10050859.Healthcare (Basel)2022Link
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel DiseasesGuillo L, Abreu M, Panaccione R, Sandborn WJ, Azevedo VF, Gensler L, Moghaddam B, Ahuja V, Ali SA, Allez M, Ananthakrishnan AN, Bhattacharya A, Dubinsky M, Griffiths A, Hart A, Korelitz B, Kotze PG, Koutroubakis IE, Lakatos PL, Lindsay JO, Magro F, Mantzaris GJ, Ng SC, O'Morain C, Panés J, Parigi T, Ran Z, Rogler G, Rubin DT, Sachar DB, Siegmund B, Steinwurz F, Tysk C, Vavricka S, Verstraete SG, Brezin AP, Haemel AK, Dignass A, Sands BE, Danese S, Peyrin-Biroulet L.Lancet Gastroenterol Hepatol. 2022 Mar;7(3):254-261. doi: 10.1016/S2468-1253(21)00297-1. Epub 2022 Jan 17.Lancet Gastroenterol Hepatol2022Link
Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with inflammatory bowel diseaseTheodoraki E, Orfanoudaki E, Foteinogiannopoulou K, Andreou NP, Gazouli M, Koutroubakis IE.Int J Colorectal Dis. 2022 Mar;37(3):639-646. doi: 10.1007/s00384-021-04091-6. Epub 2022 Jan 11.Int J Colorectal Dis2022Link
Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in GreeceGourzoulidis G, Koulentaki M, Koumarianou A, Samadas E, Androulakis N, Xynogalos S, Papakotoulas P, Boukovinas I, Karamouzis M, Souglakos J, Chotzagiannoglou V, Beletsi A, Kourlaba G.Expert Rev Pharmacoecon Outcomes Res. 2022 Mar;22(2):259-269. doi: 10.1080/14737167.2021.1921576. Epub 2021 May 6.Expert Rev Pharmacoecon Outcomes Res2022Link
Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel DiseaseOrfanoudaki E, Zacharopoulou E, Kitsou V, Karmiris K, Theodoropoulou A, Mantzaris GJ, Tzouvala M, Michopoulos S, Zampeli E, Michalopoulos G, Karatzas P, Viazis N, Liatsos C, Bamias G, Koutroubakis IE, On Behalf Of The Hellenic Group For The Study Of Ibd.J Clin Med. 2022 Jan 27;11(3):641. doi: 10.3390/jcm11030641.J Clin Med2022Link
Spontaneous bacterial peritonitis: a prospective Greek multicenter study of its epidemiology, microbiology, and outcomesSamonakis DN, Gatselis N, Bellou A, Sifaki-Pistolla D, Mela M, Demetriou G, Thalassinos E, Rigopoulou EI, Kevrekidou P, Tziortziotis I, Azariadi K, Kavousanaki M, Digenakis E, Vassiliadis T, Kouroumalis EA, Dalekos GN.Ann Gastroenterol. 2022 Jan-Feb;35(1):80-87. doi: 10.20524/aog.2021.0674. Epub 2021 Nov 10.Ann Gastroenterol2022Link
Solid extraintestinal malignancies in patients with inflammatory bowel diseaseMala A, Foteinogiannopoulou K, Koutroubakis IE.World J Gastrointest Oncol. 2021 Dec 15;13(12):1956-1980. doi: 10.4251/wjgo.v13.i12.1956.World J Gastrointest Oncol2021Link
Real-life utility and diagnostic accuracy of a home-performed fecal calprotectin test to predict endoscopic activity in patients with inflammatory bowel disease under maintenance treatment with adalimumabOrfanoudaki E, Drygiannakis I, Theodoraki E, Foteinogiannopoulou K, Mantaka A, Koutroubakis IE.Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e777-e782. doi: 10.1097/MEG.0000000000002248.Eur J Gastroenterol Hepatol2021Link
Mucocutaneous manifestations in patients with inflammatory bowel disease: a decade study from a Greek cohortKoumaki D, Machaira A, Katoulis AC, Bitados P, Orfanoudaki E, Foteinogiannopoulou K, Stefanidou M, Krasagakis K, Koutroubakis IE.Eur J Gastroenterol Hepatol. 2021 Nov 1;33(11):1387-1393. doi: 10.1097/MEG.0000000000002053.Eur J Gastroenterol Hepatol2021Link
The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn's Disease With Poor Prognostic Factors: The MODIFY StudyMantzaris GJ, Zeglinas C, Theodoropoulou A, Koutroubakis I, Orfanoudaki E, Katsanos K, Christodoulou D, Michalopoulos G, Tzouvala M, Moschovis D, Michopoulos S, Zampeli E, Soufleris K, Ilias A, Chatzievangelinou C, Kyriakakis A, Antachopoulou K, Karmiris K.Crohns Colitis 360. 2021 Sep 4;3(4):otab064. doi: 10.1093/crocol/otab064. eCollection 2021 Oct.Crohns Colitis 3602021Link
Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?Theodoraki E, Orfanoudaki E, Foteinogiannopoulou K, Legaki E, Gazouli M, Koutroubakis IE.Intest Res. 2021 Oct;19(4):461-467. doi: 10.5217/ir.2020.00042. Epub 2020 Aug 18.Intest Res2021Link
Pembrolizumab-induced antiTTG IgA-negative duodenitis treated with gluten withdrawalTheodoraki E, Giannarakis M, Tzardi M, Koutroubakis IΕ.Eur J Gastroenterol Hepatol. 2021 Aug 1;33(8):1130-1131. doi: 10.1097/MEG.0000000000002077.Eur J Gastroenterol Hepatol2021Link
Correction to: The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational studyFoteinogiannopoulou K, Karmiris K, Axiaris G, Velegraki M, Gklavas A, Kapizioni C, Karageorgos C, Kateri C, Katsoula A, Kokkotis G, Koureta E, Lamouri C, Markopoulos P, Palatianou M, Pastras P, Fasoulas K, Giouleme O, Zampeli E, Theodoropoulou A, Theocharis G, Thomopoulos K, Karatzas P, Katsanos KH, Kapsoritakis A, Kourikou A, Mathou N, Manolakopoulos S, Michalopoulos G, Michopoulos S, Boubonaris A, Bamias G, Papadopoulos V, Papatheodoridis G, Papaconstantinou I, Pachiadakis I, Soufleris K, Tzouvala M, Triantos C, Tsironi E, Christodoulou DK, Koutroubakis IE; Hellenic group for the study of IBD.BMC Gastroenterol. 2021 Jul 29;21(1):301. doi: 10.1186/s12876-021-01872-9.BMC Gastroenterol2021Link
Development of a Human Intestinal Organoid Model for In Vitro Studies on Gut Inflammation and FibrosisKandilogiannakis L, Filidou E, Drygiannakis I, Tarapatzi G, Didaskalou S, Koffa M, Arvanitidis K, Bamias G, Valatas V, Paspaliaris V, Kolios G.Stem Cells Int. 2021 Jul 27;2021:9929461. doi: 10.1155/2021/9929461. eCollection 2021.Stem Cells Int2021Link
The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational studyFoteinogiannopoulou K, Karmiris K, Axiaris G, Velegraki M, Gklavas A, Kapizioni C, Karageorgos C, Kateri C, Katsoula A, Kokkotis G, Koureta E, Lamouri C, Markopoulos P, Palatianou M, Pastras P, Fasoulas K, Giouleme O, Zampeli E, Theodoropoulou A, Theocharis G, Thomopoulos K, Karatzas P, Katsanos KH, Kapsoritakis A, Kourikou A, Mathou N, Manolakopoulos S, Michalopoulos G, Michopoulos S, Boubonaris A, Bamias G, Papadopoulos V, Papatheodoridis G, Papaconstantinou I, Pachiadakis I, Soufleris K, Tzouvala M, Triantos C, Tsironi E, Christodoulou DK, Koutroubakis IE; Hellenic group for the study of IBD.BMC Gastroenterol. 2021 Jun 29;21(1):269. doi: 10.1186/s12876-021-01826-1.BMC Gastroenterol2021Link
Immunoproliferative Small Intestinal Disease in a Liver Transplant Recipient: A Case Report and Literature ReviewOrfanoudaki E, Iliadis A, Goulis I, Xylouri E, Voumvouraki A, Samonakis DN.Exp Clin Transplant. 2021 Jun;19(6):620-623. doi: 10.6002/ect.2021.0015.Exp Clin Transplant2021Link
Osteoclast: like giant cell undiferrentiated pancreatic tumor diagnosed by means of EUS guided FNAKalogeraki A, Mouzas I, Koutroubakis IE, Moustou E, Lappa E, Tamiolakis D, Machaira A, Orfanoudaki E, Kalaitzakis E.Acta Biomed. 2021 May 12;92(2):e2021106. doi: 10.23750/abm.v92i2.9482.Acta Biomed2021Link
Extra-pleural Solitary Fibrous Tumor of the Pelvis in a Patient with Crohn's Disease Under Anti-TNF: A Case ReportFoteinogiannopoulou K, Mala A, Koutroubakis IE.Inflamm Bowel Dis. 2021 Apr 15;27(5):e55-e56. doi: 10.1093/ibd/izaa332.Inflamm Bowel Dis2021Link
Buried Bumper Syndrome: A common complication of levodopa intestinal infusion for Parkinson diseaseSpanaki C, Boura I, Avgoustaki A, Orfanoudaki E, Giannopoulou IA, Giakoumakis E, Chlouverakis G, Athanasakis E, Koulentaki M.Parkinsonism Relat Disord. 2021 Apr;85:59-62. doi: 10.1016/j.parkreldis.2021.02.032. Epub 2021 Mar 12.Parkinsonism Relat Disord2021Link
Is there any role of renin-angiotensin system inhibitors in modulating inflammatory bowel disease outcome?Mantaka A, Tsoukali E, Fragkaki M, Karmiris K, Viazis N, Mantzaris GJ, Koutroubakis IE.Eur J Gastroenterol Hepatol. 2021 Mar 1;33(3):364-371. doi: 10.1097/MEG.0000000000001912.Eur J Gastroenterol Hepatol2021Link
Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antiviralsSamonakis DN, Psyllaki M, Pavlaki KI, Drakos E, Kehagias E, Tzardi M, Papadaki HA.Ann Hepatol. 2021 Mar-Apr;21:100141. doi: 10.1016/j.aohep.2019.08.012. Epub 2019 Oct 3.Ann Hepatol2021Link
Reply to the letter to the Editor: 'The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease'Mantaka A, Tsoukali E, Fragaki M, Karmiris K, Viazis N, Mantzaris GJ, Koutroubakis IE.Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):300-302. doi: 10.1097/MEG.0000000000001777.Eur J Gastroenterol Hepatol2021Link
Autophagy in liver diseasesKouroumalis E, Voumvouraki A, Augoustaki A, Samonakis DN.World J Hepatol. 2021 Jan 27;13(1):6-65. doi: 10.4254/wjh.v13.i1.6.World J Hepatol2021Link
Sedation/Analgesia Administration Practice Varies according to Endoscopy Facility (Hospital- or Office-Based) Setting: Results from a Nationwide Survey in GreeceTziatzios G, Samonakis DN, Tsionis T, Goulas S, Christodoulou D, Triantafyllou K.Gastroenterol Res Pract. 2020 Oct 5;2020:8701791. doi: 10.1155/2020/8701791. eCollection 2020.Gastroenterol Res Pract2020Link
Hemophagocytic lymphohistiocytosis syndrome associated with Epstein-Barr infection in an immunocompetent patient. A case studyIoannou P, Akoumianaki E, Alexakis K, Proklou A, Psyllaki M, Stamatopoulos E, Koulentaki M, Kondili E, Kofteridis DP.Germs. 2020 Sep 1;10(3):266-271. doi: 10.18683/germs.2020.1216. eCollection 2020 Sep.Germs2020Link
Keeping on the High Quality of Health Care in Greek Inflammatory Bowel Disease Patients in the SARS-CoV-2 EraFoteinogiannopoulou K, Orfanoudaki E, Koutroubakis IE.Clin Gastroenterol Hepatol. 2020 Sep;18(10):2380-2381. doi: 10.1016/j.cgh.2020.04.076. Epub 2020 May 12.Clin Gastroenterol Hepatol2020Link
Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel StatementZanoli L, Mikhailidis DP, Bruno RM, Abreu MT, Danese S, Eliakim R, Gionchetti P, Katsanos KH, Kirchgesner J, Koutroubakis IE, Kucharzik T, Lakatos PL, Nguyen GC, Papa A, Vavricka SR, Wilkinson IB, Boutouyrie P.Angiology. 2020 Sep;71(8):689-697. doi: 10.1177/0003319720918509. Epub 2020 Apr 15.Angiology2020Link
Pyoderma gangrenosum associated with chronic refractory pouchitis: a case successfully treated with infliximabKoumaki D, Orfanoudaki E, Machaira A, Lagoudaki E, Krasagakis K, Koutroubakis IE.Ann Gastroenterol. 2020 Jul-Aug;33(4):433-435. doi: 10.20524/aog.2020.0500. Epub 2020 May 28.Ann Gastroenterol2020Link
Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease PatientsEliadou E, Moleiro J, Ribaldone DG, Astegiano M, Rothfuss K, Taxonera C, Ghalim F, Carbonnel F, Verstockt B, Festa S, Maia L, Berrozpe A, Zagorowicz E, Savarino E, Ellul P, Vavricka SR, Calvo M, Koutroubakis I, Hoentjen F, Salazar LF, Callela F, Cañete Pizarro F, Soufleris K, Sonnenberg E, Cavicchi M, Wypych J, Hommel C, Ghiani A, Fiorino G; ECCO CONFER COMMITTEE.J Crohns Colitis. 2020 May 21;14(4):480-489. doi: 10.1093/ecco-jcc/jjz165.J Crohns Colitis2020Link
Clinical Value of Proactive Infliximab Drug Monitoring in Patients With Inflammatory Bowel DiseaseOrfanoudaki E, Foteinogiannopoulou K, Theodoraki E, Koutroubakis IE.Inflamm Bowel Dis. 2020 May 12;26(6):e50. doi: 10.1093/ibd/izaa061.Inflamm Bowel Dis2020Link
Curative embolization of iatrogenic inferior mesenteric arteriovenous fistula 14 years after right hemicolectomyCharalambous S, Veniamin A, Valatas V, Hatzidakis A.Ann Gastroenterol. 2020 May-Jun;33(3):318-320. doi: 10.20524/aog.2020.0463. Epub 2020 Mar 14.Ann Gastroenterol2020Link
Iron Sucrose: A Wealth of Experience in Treating Iron DeficiencyMacdougall IC, Comin-Colet J, Breymann C, Spahn DR, Koutroubakis IE.Adv Ther. 2020 May;37(5):1960-2002. doi: 10.1007/s12325-020-01323-z. Epub 2020 Apr 15.Adv Ther2020Link
Dietary Guidance From the International Organization for the Study of Inflammatory Bowel DiseasesLevine A, Rhodes JM, Lindsay JO, Abreu MT, Kamm MA, Gibson PR, Gasche C, Silverberg MS, Mahadevan U, Boneh RS, Wine E, Damas OM, Syme G, Trakman GL, Yao CK, Stockhamer S, Hammami MB, Garces LC, Rogler G, Koutroubakis IE, Ananthakrishnan AN, McKeever L, Lewis JD.Clin Gastroenterol Hepatol. 2020 May;18(6):1381-1392. doi: 10.1016/j.cgh.2020.01.046. Epub 2020 Feb 15.Clin Gastroenterol Hepatol2020Link
The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel diseaseMantaka A, Tsoukali E, Fragkaki M, Karmiris K, Viazis N, Mantzaris GJ, Koutroubakis IE.Eur J Gastroenterol Hepatol. 2020 May;32(5):581-587. doi: 10.1097/MEG.0000000000001674.Eur J Gastroenterol Hepatol2020Link
Comparison of the Uptake of Screening Colonoscopy between Physicians and the General Population in GreeceViazis N, Tzouvala M, Theodoropoulou A, Giouleme O, Thomopoulos K, Christodoulou DK, Michopoulos S, Soufleris K, Koutroubakis I, Karamanolis G, Papatheodoridis G, Giotis I, Paspatis G, Mantzaris GJ.Dig Dis. 2020;38(1):23-30. doi: 10.1159/000501266. Epub 2019 Jul 9.Dig Dis2020Link
Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative?Fragaki M, Sifaki-Pistolla D, Orfanoudaki E, Kouroumalis E.Ann Gastroenterol. 2019 Nov-Dec;32(6):626-632. doi: 10.20524/aog.2019.0417. Epub 2019 Sep 26.Ann Gastroenterol2019Link
Understanding the Interplay between COX-2 and hTERT in Colorectal Cancer Using a Multi-Omics AnalysisAyiomamitis GD, Notas G, Vasilakaki T, Tsavari A, Vederaki S, Theodosopoulos T, Kouroumalis E, Zaravinos A.Cancers (Basel). 2019 Oct 11;11(10):1536. doi: 10.3390/cancers11101536.Cancers (Basel)2019Link
Letter to the Editor: Is There a Role for Switching Infliximab in Order to Regain Anti-TNF Response in Cases With Active Inflammatory Bowel Disease?Mantaka A, Orfanoudaki E, Koutroubakis IE.Inflamm Bowel Dis. 2019 Sep 18;25(10):e120. doi: 10.1093/ibd/izz153.Inflamm Bowel Dis2019Link
SEMS and Sensibility: Self-Expandable Metal Stents for Malignant Biliary Obstruction-Are Stent Characteristics Important?Kalaitzakis E.Dig Dis Sci. 2019 Sep;64(9):2376-2378. doi: 10.1007/s10620-019-05742-z.Dig Dis Sci2019Link
Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in GreeceViazis N, Pontas C, Karmiris K, Dimas I, Fragaki M, Paspatis G, Drygiannakis I, Koutroubakis IE, Moschovis D, Tzouvala M, Theocharis G, Tsolias C, Thomopoulos K, Zampeli E, Axiaris G, Michopoulos S, Belesiotou E, Banasa M, Maraki S, Kouskoumpekou F, Apostolopoulos G, Stamouli V, Prifti H, Mantzaris GJ.Eur J Gastroenterol Hepatol. 2019 Jul;31(7):773-776. doi: 10.1097/MEG.0000000000001414.Eur J Gastroenterol Hepatol2019Link
Inflammatory Bowel Disease [IBD] and Physical Activity: A Study on the Impact of Diagnosis on the Level of Exercise Amongst Patients With IBDGatt K, Schembri J, Katsanos KH, Christodoulou D, Karmiris K, Kopylov U, Pontas C, Koutroubakis IE, Foteinogiannopoulou K, Fabian A, Molnar T, Zammit D, Fragaki M, Balomenos D, Zingboim N, Ben Horin S, Mantzaris GJ, Ellul P.J Crohns Colitis. 2019 May 27;13(6):686-692. doi: 10.1093/ecco-jcc/jjy214.J Crohns Colitis2019Link
Risk Factors of Colectomy in Patients With Refractory Ulcerative Colitis Under Calcineurin Inhibitors Combined With VedolizumabFragaki M, Demetriou G, Koutroubakis IE.Clin Gastroenterol Hepatol. 2019 May;17(6):1213-1214. doi: 10.1016/j.cgh.2018.12.004.Clin Gastroenterol Hepatol2019Link
TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal ImmunityValatas V, Kolios G, Bamias G.Front Immunol. 2019 Mar 27;10:583. doi: 10.3389/fimmu.2019.00583. eCollection 2019.Front Immunol2019Link
Liver Transplantation for Familial Amyloid Polyneuropathy (Val30Met): Long-Term Follow-up Prospective Study in a Nontransplant CenterKavousanaki M, Tzagournissakis Μ, Zaganas I, Stylianou KG, Patrianakos AP, Tsilimbaris MK, Mantaka A, Samonakis DN.Transplant Proc. 2019 Mar;51(2):429-432. doi: 10.1016/j.transproceed.2019.01.071. Epub 2019 Jan 29.Transplant Proc2019Link
Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximabOrfanoudaki E, Gazouli M, Foteinogiannopoulou K, Theodoraki E, Legaki E, Romanos I, Mouzas I, Koutroubakis IE.Eur J Gastroenterol Hepatol. 2019 Feb;31(2):187-191. doi: 10.1097/MEG.0000000000001332.Eur J Gastroenterol Hepatol2019Link
Gut Microbial Signatures Underline Complicated Crohn's Disease but Vary Between Cohorts; An In Silico ApproachDovrolis N, Drygiannakis I, Filidou E, Kandilogiannakis L, Arvanitidis K, Tentes I, Kolios G, Valatas V.Inflamm Bowel Dis. 2019 Jan 10;25(2):217-225. doi: 10.1093/ibd/izy328.Inflamm Bowel Dis2019Link
ReplyRokkas T, Portincasa P, Koutroubakis IE.J Gastrointestin Liver Dis. 2018 Dec;27(4):474-475. doi: 10.15403/jgld.2014.1121.274.ply.J Gastrointestin Liver Dis2018Link
Association of smoking with liver fibrosis and mortality in primary biliary cholangitisMantaka A, Koulentaki M, Samonakis D, Sifaki-Pistolla D, Voumvouraki A, Tzardi M, Kouroumalis E.Eur J Gastroenterol Hepatol. 2018 Dec;30(12):1461-1469. doi: 10.1097/MEG.0000000000001234.Eur J Gastroenterol Hepatol2018Link
Letter: is there a role for infliximab biosimilar in patients with inflammatory bowel disease with secondary loss of response to infliximab innovator?Orfanoudaki E, Drygiannakis I, Koutroubakis IE.Aliment Pharmacol Ther. 2018 Nov;48(9):1037-1038. doi: 10.1111/apt.14980.Aliment Pharmacol Ther2018Link
The Length of Surgical Skin Incision in Postoperative Inflammatory ReactionIoannidis A, Arvanitidis K, Filidou E, Valatas V, Stavrou G, Michalopoulos A, Kolios G, Kotzampassi K.JSLS. 2018 Oct-Dec;22(4):e2018.00045. doi: 10.4293/JSLS.2018.00045.JSLS2018Link
Screening for Hepatopulmonary Syndrome in Cirrhotic Patients Using Technetium 99m-macroaggregated Albumin Perfusion Lung Scan (Tc-MAA): Diagnostic Approach and Clinical CorrelationsFragaki M, Sifaki-Pistolla D, Samonakis DN, Koulentaki M, Koukouraki S, Stathaki M, Kouroumalis E.J Clin Gastroenterol. 2018 Oct;52(9):828-834. doi: 10.1097/MCG.0000000000000926.J Clin Gastroenterol2018Link
Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a reviewGalanakis N, Kehagias E, Matthaiou N, Samonakis D, Tsetis D.Hepat Oncol. 2018 Sep 28;5(2):HEP07. doi: 10.2217/hep-2018-0001. eCollection 2018 Apr.Hepat Oncol2018Link
Cytokine Receptor Profiling in Human Colonic Subepithelial Myofibroblasts: A Differential Effect of Th Polarization-Associated Cytokines in Intestinal FibrosisFilidou E, Valatas V, Drygiannakis I, Arvanitidis K, Vradelis S, Kouklakis G, Kolios G, Bamias G.Inflamm Bowel Dis. 2018 Sep 15;24(10):2224-2241. doi: 10.1093/ibd/izy204.Inflamm Bowel Dis2018Link
Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysisRokkas T, Portincasa P, Koutroubakis IE.J Gastrointestin Liver Dis. 2018 Sep;27(3):299-306. doi: 10.15403/jgld.2014.1121.273.pti.J Gastrointestin Liver Dis2018Link
Biomarkers for primary biliary cholangitis: current perspectivesKouroumalis E, Samonakis D, Voumvouraki A.Hepat Med. 2018 Jun 18;10:43-53. doi: 10.2147/HMER.S135337. eCollection 2018.Hepat Med2018Link
GABA(A) receptor polymorphisms in alcohol use disorder in the GWAS eraKoulentaki M, Kouroumalis E.Psychopharmacology (Berl). 2018 Jun;235(6):1845-1865. doi: 10.1007/s00213-018-4918-4. Epub 2018 May 2.Psychopharmacology (Berl)2018Link
Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel DiseaseTheodoraki E, Orfanoudaki E, Foteinogiannopoulou K, Koutroubakis IE.Inflamm Bowel Dis. 2018 May 18;24(6):1266-1271. doi: 10.1093/ibd/izy088.Inflamm Bowel Dis2018Link
Use of vedolizumab in a patient with chronic and refractory pouchitisOrfanoudaki E, Foteinogiannopoulou K, Koutroubakis IE.Ann Gastroenterol. 2018 May-Jun;31(3):379. doi: 10.20524/aog.2018.0243. Epub 2018 Mar 3.Ann Gastroenterol2018Link
Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challengesMantaka A, Augoustaki A, Kouroumalis EA, Samonakis DN.Ann Gastroenterol. 2018 May-Jun;31(3):315-329. doi: 10.20524/aog.2018.0245. Epub 2018 Mar 3.Ann Gastroenterol2018Link
Angiodrastic Chemokines in Colorectal Cancer: Clinicopathological CorrelationsEmmanouil G, Ayiomamitis G, Zizi-Sermpetzoglou A, Tzardi M, Moursellas A, Voumvouraki A, Kouroumalis E.Anal Cell Pathol (Amst). 2018 Apr 16;2018:1616973. doi: 10.1155/2018/1616973. eCollection 2018.Anal Cell Pathol (Amst)2018Link
Activin-A causes Hepatic stellate cell activation via the induction of TNFα and TGFβ in Kupffer cellsKiagiadaki F, Kampa M, Voumvouraki A, Castanas E, Kouroumalis E, Notas G.Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):891-899. doi: 10.1016/j.bbadis.2017.12.031. Epub 2017 Dec 26.Biochim Biophys Acta Mol Basis Dis2018Link
Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countriesLeblebicioglu H, Arends JE, Ozaras R, Corti G, Santos L, Boesecke C, Ustianowski A, Duberg AS, Ruta S, Salkic NN, Husa P, Lazarevic I, Pineda JA, Pshenichnaya NY, Tsertswadze T, Matičič M, Puca E, Abuova G, Gervain J, Bayramli R, Ahmeti S, Koulentaki M, Kilani B, Vince A, Negro F, Sunbul M, Salmon D; ESGHV (part of ESCMID).Antiviral Res. 2018 Feb;150:9-14. doi: 10.1016/j.antiviral.2017.12.001. Epub 2017 Dec 5.Antiviral Res2018Link
Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, GreeceCoucoutsi C, Emmanouil G, Goulielmos G, Sfakianaki O, Koutroubakis IE, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1284-1289. doi: 10.1097/MEG.0000000000000947.Eur J Gastroenterol Hepatol2017Link
New-onset severe hypercholesterolemia in a patient with cholestatic liver disease. Should we treat the lipids?Papakonstantinou PE, Theodoraki E, Koulentaki M, Papadakis JA.Hellenic J Cardiol. 2017 Jul-Aug;58(4):300-302. doi: 10.1016/j.hjc.2016.12.009. Epub 2017 Jan 28.Hellenic J Cardiol2017Link
Ultrasound-guided direct intrahepatic portosystemic shunt in patients with Budd-Chiari syndrome: Short- and long-term resultsHatzidakis A, Galanakis N, Kehagias E, Samonakis D, Koulentaki M, Matrella E, Tsetis D.Interv Med Appl Sci. 2017 Jun;9(2):86-93. doi: 10.1556/1646.9.2017.2.14.Interv Med Appl Sci2017Link
Crohn's disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cellsBamias G, Filidou E, Goukos D, Valatas V, Arvanitidis K, Panagopoulou M, Kouklakis G, Daikos GL, Ladas SD, Kolios G.Transl Res. 2017 Feb;180:118-130.e2. doi: 10.1016/j.trsl.2016.08.007. Epub 2016 Sep 7.Transl Res2017Link
Systemic treatment for hepatocellular carcinoma: Still unmet expectationsSamonakis DN, Kouroumalis EA.World J Hepatol. 2017 Jan 18;9(2):80-90. doi: 10.4254/wjh.v9.i2.80.World J Hepatol2017Link
Stromal and immune cells in gut fibrosis: the myofibroblast and the scarfaceValatas V, Filidou E, Drygiannakis I, Kolios G.Ann Gastroenterol. 2017;30(4):393-404. doi: 10.20524/aog.2017.0146. Epub 2017 Apr 12.Ann Gastroenterol2017Link
Long-term change in incidence and risk factors of cirrhosis and hepatocellular carcinoma in Crete, Greece: a 25-year studyKarageorgos SA, Stratakou S, Koulentaki M, Voumvouraki A, Mantaka A, Samonakis D, Notas G, Kouroumalis EA.Ann Gastroenterol. 2017;30(3):357-363. doi: 10.20524/aog.2017.0135. Epub 2017 Mar 23.Ann Gastroenterol2017Link
Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel diseaseTerzoudis S, Malliaraki N, Damilakis J, Dimitriadou DA, Zavos C, Koutroubakis IE.Eur J Gastroenterol Hepatol. 2016 Jul;28(7):814-9. doi: 10.1097/MEG.0000000000000617.Eur J Gastroenterol Hepatol2016Link
Results of the Fifth Scientific Workshop of the ECCO [II]: Clinical Aspects of Perianal Fistulising Crohn's Disease-the Unmet NeedsGecse KB, Sebastian S, Hertogh Gd, Yassin NA, Kotze PG, Reinisch W, Spinelli A, Koutroubakis IE, Katsanos KH, Hart A, van den Brink GR, Rogler G, Bemelman WA.J Crohns Colitis. 2016 Jul;10(7):758-65. doi: 10.1093/ecco-jcc/jjw039. Epub 2016 Jan 28.J Crohns Colitis2016Link
Distinct features of circulating microparticles and their relationship with disease activity in inflammatory bowel diseaseVoudoukis E, Vetsika EK, Giannakopoulou K, Karmiris K, Theodoropoulou A, Sfiridaki A, Georgoulias V, Paspatis GA, Koutroubakis IE.Ann Gastroenterol. 2016 Apr-Jun;29(2):180-7. doi: 10.20524/aog.2016.0010.Ann Gastroenterol2016Link
Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel DiseaseKarmiris K, Avgerinos A, Tavernaraki A, Zeglinas C, Karatzas P, Koukouratos T, Oikonomou KA, Kostas A, Zampeli E, Papadopoulos V, Theodoropoulou A, Viazis N, Polymeros D, Michopoulos S, Bamias G, Kapsoritakis A, Karamanolis DG, Mantzaris GJ, Tzathas C, Koutroubakis IE.J Crohns Colitis. 2016 Apr;10(4):429-36. doi: 10.1093/ecco-jcc/jjv232. Epub 2015 Dec 30.J Crohns Colitis2016Link
Geoepidemiology of hepatocellular carcinoma in the island of Crete, Greece. A possible role of pesticidesSifaki-Pistolla D, Karageorgos SA, Koulentaki M, Samonakis D, Stratakou S, Digenakis E, Kouroumalis E.Liver Int. 2016 Apr;36(4):588-94. doi: 10.1111/liv.13034. Epub 2015 Dec 25.Liver Int2016Link
Lymphangiogenesis in Inflammatory Bowel Disease; A New Therapeutic Target?Koutroubakis IE, Binion DG.Clin Transl Gastroenterol. 2016 Mar 17;7(3):e154. doi: 10.1038/ctg.2015.68.Clin Transl Gastroenterol2016Link
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel DiseaseHarbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, Burisch J, De Vos M, De Vries AM, Dick AD, Juillerat P, Karlsen TH, Koutroubakis I, Lakatos PL, Orchard T, Papay P, Raine T, Reinshagen M, Thaci D, Tilg H, Carbonnel F; European Crohn’s and Colitis Organisation.J Crohns Colitis. 2016 Mar;10(3):239-54. doi: 10.1093/ecco-jcc/jjv213. Epub 2015 Nov 27.J Crohns Colitis2016Link
Percutaneous rheolytic mechanical thrombectomy in thrombosed direct intrahepatic portosystemic shunt: Report of two casesTsetis D, Kehagias E, Samonakis D, Kouroumalis E, Hatzidakis A.Interv Med Appl Sci. 2015 Dec;7(4):171-5. doi: 10.1556/1646.7.2015.4.7.Interv Med Appl Sci2015Link
Acute TIPS occlusion due to iatrogenic arteriovenous shunt in a cirrhotic patient with total portal vein thrombosisHatzidakis A, Kouroumalis E, Kehagias E, Digenakis E, Samonakis D, Tsetis D.Interv Med Appl Sci. 2015 Dec;7(4):166-70. doi: 10.1556/1646.7.2015.4.6.Interv Med Appl Sci2015Link
Clinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelinesMantzaris GJ, Viazis N, Polymeros D, Papamichael K, Bamias G, Koutroubakis IE.Ann Gastroenterol. 2015 Oct-Dec;28(4):417-25.Ann Gastroenterol2015Link
Primary biliary cirrhosis: From bench to bedsideKouroumalis E, Notas G.World J Gastrointest Pharmacol Ther. 2015 Aug 6;6(3):32-58. doi: 10.4292/wjgpt.v6.i3.32.World J Gastrointest Pharmacol Ther2015Link
Intraperitoneal application of phospholipids for the prevention of postoperative adhesions: a possible role of myofibroblastsFotiadis K, Filidou E, Arvanitidis K, Valatas V, Stavrou G, Basdanis G, Paspaliaris V, Kolios G, Kotzampassi K.J Surg Res. 2015 Aug;197(2):291-300. doi: 10.1016/j.jss.2015.04.036. Epub 2015 Apr 16.J Surg Res2015Link
Experimental colitis models: Insights into the pathogenesis of inflammatory bowel disease and translational issuesValatas V, Bamias G, Kolios G.Eur J Pharmacol. 2015 Jul 15;759:253-64. doi: 10.1016/j.ejphar.2015.03.017. Epub 2015 Mar 23.Eur J Pharmacol2015Link
The relationship between coagulation state and inflammatory bowel disease: current understanding and clinical implicationsKoutroubakis IE.Expert Rev Clin Immunol. 2015 Apr;11(4):479-88. doi: 10.1586/1744666X.2015.1019475. Epub 2015 Feb 26.Expert Rev Clin Immunol2015Link
European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseasesDignass AU, Gasche C, Bettenworth D, Birgegård G, Danese S, Gisbert JP, Gomollon F, Iqbal T, Katsanos K, Koutroubakis I, Magro F, Savoye G, Stein J, Vavricka S; European Crohn’s and Colitis Organisation [ECCO].J Crohns Colitis. 2015 Mar;9(3):211-22. doi: 10.1093/ecco-jcc/jju009. Epub 2014 Dec 3.J Crohns Colitis2015Link
Telomerase: a target for colorectal cancer treatment?Kouroumalis E.Cell Cycle. 2015;14(22):3513-4. doi: 10.1080/15384101.2015.1032638.Cell Cycle2015Link
Ulcerative colitis and Budd-Chiari syndrome: which comes first?Mantaka AN, Samonakis DN, Liontiris M, Koutroubakis IE.Eur J Gastroenterol Hepatol. 2014 Nov;26(11):1306. doi: 10.1097/MEG.0000000000000183.Eur J Gastroenterol Hepatol2014Link
The bone and fat connection in inflammatory bowel diseasesTerzoudis S, Zavos C, Koutroubakis IE.Inflamm Bowel Dis. 2014 Nov;20(11):2207-17. doi: 10.1097/MIB.0000000000000111.Inflamm Bowel Dis2014Link
Higher free serum cortisol is associated with worse survival in acute variceal bleeding because of cirrhosis: a prospective studyTriantos CK, Kalafateli M, Samonakis D, Zisimopoulos K, Papiamonis N, Sapountzis A, Michalaki M, Theocharis G, Thomopoulos K, Labropoulou-Karatza C, Kyriazopoulou V, Jelastopulu E, Kouroumalis EA, Nikolopoulou V, Burroughs AK.Eur J Gastroenterol Hepatol. 2014 Oct;26(10):1125-32. doi: 10.1097/MEG.0000000000000158.Eur J Gastroenterol Hepatol2014Link
Geoepidemiology and space-time analysis of Primary biliary cirrhosis in Crete, GreeceKoulentaki M, Mantaka A, Sifaki-Pistolla D, Thalassinos E, Tzanakis N, Kouroumalis E.Liver Int. 2014 Aug;34(7):e200-7. doi: 10.1111/liv.12479. Epub 2014 Mar 7.Liver Int2014Link
Clinical outcomes of compensated and decompensated cirrhosis: A long term studySamonakis DN, Koulentaki M, Coucoutsi C, Augoustaki A, Baritaki C, Digenakis E, Papiamonis N, Fragaki M, Matrella E, Tzardi M, Kouroumalis EA.World J Hepatol. 2014 Jul 27;6(7):504-12. doi: 10.4254/wjh.v6.i7.504.World J Hepatol2014Link
Effects of octreotide and insulin on colon cancer cellular proliferation and correlation with hTERT activityAyiomamitis GD, Notas G, Zaravinos A, Drygiannakis I, Georgiadou M, Sfakianaki O, Mastrodimou N, Thermos K, Kouroumalis E.Oncoscience. 2014 Jun 30;1(6):457-67. doi: 10.18632/oncoscience.58. eCollection 2014.Oncoscience2014Link
Multipotent role of platelets in inflammatory bowel diseases: a clinical approachVoudoukis E, Karmiris K, Koutroubakis IE.World J Gastroenterol. 2014 Mar 28;20(12):3180-90. doi: 10.3748/wjg.v20.i12.3180.World J Gastroenterol2014Link
Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cellsKlironomos S, Notas G, Sfakianaki O, Kiagiadaki F, Xidakis C, Kouroumalis E.Regul Pept. 2014 Jan 10;188:5-12. doi: 10.1016/j.regpep.2013.11.002. Epub 2013 Nov 26.Regul Pept2014Link
Gastric non-Hodgkin's lymphomaTzimourtos V, Samonakis D, Tzardi M, Koutroubakis IE.Ann Gastroenterol. 2014;27(2):167.Ann Gastroenterol2014Link
The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseasesValatas V, Vakas M, Kolios G.Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(11):G763-85. doi: 10.1152/ajpgi.00004.2013. Epub 2013 Aug 29.Am J Physiol Gastrointest Liver Physiol2013Link
Epidemiology and molecular analysis of hepatitis A, B and C in a semi-urban and rural area of CreteDrositis I, Bertsias A, Lionis C, Kouroumalis E.Eur J Intern Med. 2013 Dec;24(8):839-45. doi: 10.1016/j.ejim.2013.08.003. Epub 2013 Aug 26.Eur J Intern Med2013Link
Presence of disease specific autoantibodies against liver sinusoidal cells in primary biliary cirrhosisSfakianaki O, Tzardi M, Voumvouraki A, Afgoustaki A, Koulentaki M, Kouroumalis E.World J Hepatol. 2013 Oct 27;5(10):568-76. doi: 10.4254/wjh.v5.i10.568.World J Hepatol2013Link
Association between thrombocytosis and iron deficiency anemia in inflammatory bowel diseaseVoudoukis E, Karmiris K, Oustamanolakis P, Theodoropoulou A, Sfiridaki A, Paspatis GA, Koutroubakis IE.Eur J Gastroenterol Hepatol. 2013 Oct;25(10):1212-6. doi: 10.1097/MEG.0b013e328363e354.Eur J Gastroenterol Hepatol2013Link
Cornelia de Lange syndrome in association with ulcerative colitis: a case reportPapiamonis N, Koutroubakis IE.J Crohns Colitis. 2013 Oct;7(9):e399-400. doi: 10.1016/j.crohns.2013.03.010. Epub 2013 Apr 12.J Crohns Colitis2013Link
Risk of venous thromboembolism in patients with inflammatory bowel diseaseKoutroumpakis EI, Tsiolakidou G, Koutroubakis IE.Semin Thromb Hemost. 2013 Jul;39(5):461-8. doi: 10.1055/s-0033-1343886. Epub 2013 Apr 29.Semin Thromb Hemost2013Link
Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: implication in intestinal fibrosisDrygiannakis I, Valatas V, Sfakianaki O, Bourikas L, Manousou P, Kambas K, Ritis K, Kolios G, Kouroumalis E.J Crohns Colitis. 2013 May;7(4):286-300. doi: 10.1016/j.crohns.2012.04.008. Epub 2012 May 9.J Crohns Colitis2013Link
CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acidManousou P, Kolios G, Drygiannakis I, Koulentaki M, Pyrovolaki K, Voumvouraki A, Notas G, Bourikas L, Papadaki HA, Kouroumalis E.Clin Exp Immunol. 2013 Apr;172(1):9-15. doi: 10.1111/cei.12032.Clin Exp Immunol2013Link
Increased fracture risk assessed by fracture risk assessment tool in Greek patients with Crohn's diseaseTerzoudis S, Zavos C, Damilakis J, Neratzoulakis J, Dimitriadi DA, Roussomoustakaki M, Kouroumalis EA, Koutroubakis IE.Dig Dis Sci. 2013 Jan;58(1):216-21. doi: 10.1007/s10620-012-2326-x. Epub 2012 Aug 3.Dig Dis Sci2013Link
Genetic variants associated with susceptibility to mother-to-child transmission of hepatitis B virusChatzidaki V, Choumerianou D, Dimitriou H, Kouroumalis E, Galanakis E.Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1185-90. doi: 10.1097/MEG.0b013e328356440f.Eur J Gastroenterol Hepatol2012Link
Primary biliary cirrhosis in a genetically homogeneous population: disease associations and familial occurrence ratesMantaka A, Koulentaki M, Chlouverakis G, Enele-Melono JM, Darivianaki A, Tzardi M, Kouroumalis EA.BMC Gastroenterol. 2012 Aug 16;12:110. doi: 10.1186/1471-230X-12-110.BMC Gastroenterol2012Link
Polymorphisms of genes related to endothelial cells are associated with primary biliary cirrhosis patients of Cretan originMantaka A, Goulielmos GN, Koulentaki M, Tsagournis O, Voumvouraki A, Kouroumalis EA.Hum Immunol. 2012 Aug;73(8):829-35. doi: 10.1016/j.humimm.2012.05.003. Epub 2012 May 18.Hum Immunol2012Link
Increased serum activin-A differentiates alcoholic from cirrhosis of other aetiologiesVoumvouraki A, Notas G, Koulentaki M, Georgiadou M, Klironomos S, Kouroumalis E.Eur J Clin Invest. 2012 Aug;42(8):815-22. doi: 10.1111/j.1365-2362.2012.02647.x. Epub 2012 Feb 4.Eur J Clin Invest2012Link
The Janus tyrosine kinase-2 V617F mutation is not implicated in the pathogenesis of ischemic colitis in young patientsKonstantinidis K, Theodoropoulou A, Sfiridaki A, Georgousaki C, Tsatsaki D, Paspatis GA, Koutroubakis IE.J Clin Gastroenterol. 2012 May-Jun;46(5):433-4. doi: 10.1097/MCG.0b013e3182436403.J Clin Gastroenterol2012Link
Radiation protection in digestive endoscopy: European Society of Digestive Endoscopy (ESGE) guidelineDumonceau JM, Garcia-Fernandez FJ, Verdun FR, Carinou E, Donadille L, Damilakis J, Mouzas I, Paraskeva K, Ruiz-Lopez N, Struelens L, Tsapaki V, Vanhavere F, Valatas V, Sans-Merce M; European Society of Digestive Endoscopy.Endoscopy. 2012 Apr;44(4):408-21. doi: 10.1055/s-0031-1291791. Epub 2012 Mar 21.Endoscopy2012Link
Klippel-Trénaunay syndrome, pregnancy and the liver: an unusual interplaySamonakis DN, Oustamanolakis P, Manousou P, Kouroumalis EA, Burroughs AK.Ann Gastroenterol. 2012;25(4):365-367.Ann Gastroenterol2012Link
Eosinophilic gastroenteritis associated with Churg-Strauss syndromeAvgerinos A, Bourikas L, Tzardi M, Koutroubakis IE.Ann Gastroenterol. 2012;25(2):164.Ann Gastroenterol2012Link
Acute pulmonary embolism following N-butyl-cyanoacrylate endoscopic injection sclerotherapyPapiamonis NE, Matrella E, Blevrakis EG, Kouroumalis EA.Ann Gastroenterol. 2012;25(3):261.Ann Gastroenterol2012Link
Assessment of a postoperative anastomotic stricture following correction surgery of a type IVa choledochal cyst using Gd-EOB-DTPA-enhanced magnetic resonance cholangiographyPerdikakis E, Chryssou EG, Koulentaki M, Kouroumalis E, Karantanas A.Clin J Gastroenterol. 2011 Dec;4(6):396-400. doi: 10.1007/s12328-011-0261-6. Epub 2011 Nov 1.Clin J Gastroenterol2011Link
Soluble transferrin receptor-ferritin index is the most efficient marker for the diagnosis of iron deficiency anemia in patients with IBDOustamanolakis P, Koutroubakis IE.Inflamm Bowel Dis. 2011 Dec;17(12):E158-9. doi: 10.1002/ibd.21881. Epub 2011 Sep 26.Inflamm Bowel Dis2011Link
Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up studyKatsanos KH, Tatsioni A, Pedersen N, Shuhaibar M, Ramirez VH, Politi P, Rombrechts E, Pierik M, Clofent J, Beltrami M, Bodini P, Freitas J, Mouzas I, Fornaciari G, Moum B, Lakatos PL, Vermeire S, Langholz E, Odes S, Morain CO, Stockbrügger R, Munkholm P, Tsianos EV.J Crohns Colitis. 2011 Oct;5(5):430-42. doi: 10.1016/j.crohns.2011.04.013. Epub 2011 May 18.J Crohns Colitis2011Link
Diagnosing anemia in inflammatory bowel disease: beyond the established markersOustamanolakis P, Koutroubakis IE, Kouroumalis EA.J Crohns Colitis. 2011 Oct;5(5):381-91. doi: 10.1016/j.crohns.2011.03.010. Epub 2011 Apr 27.J Crohns Colitis2011Link
TNF receptors in Kupffer cellsGeorgiadou M, Notas G, Xidakis C, Drygiannakis I, Sfakianaki O, Klironomos S, Valatas V, Kouroumalis E.J Recept Signal Transduct Res. 2011 Aug;31(4):291-8. doi: 10.3109/10799893.2011.586354. Epub 2011 Jun 21.J Recept Signal Transduct Res2011Link
Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel diseaseOustamanolakis P, Koutroubakis IE, Messaritakis I, Kefalogiannis G, Niniraki M, Kouroumalis EA.J Crohns Colitis. 2011 Aug;5(4):295-300. doi: 10.1016/j.crohns.2011.02.002. Epub 2011 Apr 3.J Crohns Colitis2011Link
Role of ghrelin and insulin-like growth factor binding protein-3 in the development of osteoporosis in inflammatory bowel diseaseKoutroubakis IE, Zavos C, Damilakis J, Papadakis G, Neratzoulakis J, Karkavitsas N, Kouroumalis EA.J Clin Gastroenterol. 2011 Jul;45(6):e60-5. doi: 10.1097/MCG.0b013e3181f42543.J Clin Gastroenterol2011Link
Acute generalized exanthematous pustulosis induced by azathioprine in a patient with ulcerative colitisAvgerinos A, Giannikaki E, Krüger-Krasagakis S, Koutroubakis IE.Am J Gastroenterol. 2011 May;106(5):1005-7. doi: 10.1038/ajg.2010.500.Am J Gastroenterol2011Link
Serum hepcidin and prohepcidin concentrations in inflammatory bowel diseaseOustamanolakis P, Koutroubakis IE, Messaritakis I, Malliaraki N, Sfiridaki A, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2011 Mar;23(3):262-8. doi: 10.1097/MEG.0b013e328343b885.Eur J Gastroenterol Hepatol2011Link
Antiglycan antibodies in Greek patients with inflammatory bowel diseaseKoutroubakis IE, Drygiannakis D, Tsirogianni A, Oustamanolakis P, Karmiris K, Papamichael K, Mantzaris GJ, Kouroumalis EA.Dig Dis Sci. 2011 Mar;56(3):845-52. doi: 10.1007/s10620-010-1328-9. Epub 2010 Jul 15.Dig Dis Sci2011Link
Upper gastrointestinal endoscopy for dyspepsia: exploratory study of factors influencing patient compliance in GreeceOikonomidou E, Anastasiou F, Pilpilidis I, Kouroumalis E, Lionis C; Greek General Practice Dyspepsia Group.BMC Gastroenterol. 2011 Feb 14;11:11. doi: 10.1186/1471-230X-11-11.BMC Gastroenterol2011Link
Serum surrogate markers of liver fibrosis in primary biliary cirrhosisVoumvouraki A, Koulentaki M, Notas G, Sfakianaki O, Kouroumalis E.Eur J Intern Med. 2011 Feb;22(1):77-83. doi: 10.1016/j.ejim.2010.10.002. Epub 2010 Nov 13.Eur J Intern Med2011Link
Epstein Barr virus hepatitisKofteridis DP, Koulentaki M, Valachis A, Christofaki M, Mazokopakis E, Papazoglou G, Samonis G.Eur J Intern Med. 2011 Feb;22(1):73-6. doi: 10.1016/j.ejim.2010.07.016. Epub 2010 Aug 19.Eur J Intern Med2011Link
New desensitization regimen with mesalamine granules in a patient with ulcerative colitis and mesalamine intoleranceOustamanolakis P, Koutroubakis IE.Inflamm Bowel Dis. 2011 Feb;17(2):E8-9. doi: 10.1002/ibd.21323.Inflamm Bowel Dis2011Link
Autoimmune pancreatitis. A rare cause of cholestasisKoulentaki M, Chryssou E, Coucoutsi C, Koutroubakis I.Dig Liver Dis. 2011 Feb;43(2):e3. doi: 10.1016/j.dld.2009.12.002. Epub 2010 Feb 25.Dig Liver Dis2011Link
Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cellsTsagarakis NJ, Drygiannakis I, Batistakis AG, Kolios G, Kouroumalis EA.World J Gastroenterol. 2011 Jan 21;17(3):313-21. doi: 10.3748/wjg.v17.i3.313.World J Gastroenterol2011Link
Low bone mineral density in Greek patients with inflammatory bowel disease: prevalence and risk factorsKoutroubakis IE, Zavos C, Damilakis J, Papadakis GZ, Neratzoulakis J, Karkavitsas N, Kouroumalis EA.Ann Gastroenterol. 2011;24(1):41-46.Ann Gastroenterol2011Link
An unusual infection on an unusual gastroenteritisZavos C, Samonakis DN, Melono JM, Voloudaki A, Grammatikakis J, Kouroumalis EA.Ann Gastroenterol. 2011;24(4):325-327.Ann Gastroenterol2011Link
Pseudomembranous colitis with presence of signet - ring cells: report of two cases and review of the literatureTzardi M, Papadakis M, Giannikaki E, Datseri G, Kouroumalis EA, Kalogeraki A.Ann Gastroenterol. 2011;24(3):222-224.Ann Gastroenterol2011Link
Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control studyOustamanolakis P, Koutroubakis IE, Messaritakis I, Niniraki M, Kouroumalis EA.Ann Gastroenterol. 2011;24(2):108-114.Ann Gastroenterol2011Link
Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studiesManousou P, Kolios G, Valatas V, Drygiannakis I, Bourikas L, Pyrovolaki K, Koutroubakis I, Papadaki HA, Kouroumalis E.Clin Exp Immunol. 2010 Nov;162(2):337-47. doi: 10.1111/j.1365-2249.2010.04248.x.Clin Exp Immunol2010Link
Increased ΤGF-β3 in primary biliary cirrhosis: an abnormality related to pathogenesis?Voumvouraki A, Koulentaki M, Tzardi M, Sfakianaki O, Manousou P, Notas G, Kouroumalis E.World J Gastroenterol. 2010 Oct 28;16(40):5057-64. doi: 10.3748/wjg.v16.i40.5057.World J Gastroenterol2010Link
Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patientsSfakianaki O, Koulentaki M, Tzardi M, Tsangaridou E, Theodoropoulos PA, Castanas E, Kouroumalis EA.World J Gastroenterol. 2010 Oct 21;16(39):4938-43. doi: 10.3748/wjg.v16.i39.4938.World J Gastroenterol2010Link
A case of orbital myositis preceding the intestinal symptoms of Crohn's diseaseBourikas LA, Roussomoustakaki M, Papadaki E, Valatas V, Koutroubakis IE, Papadakis KA, Kouroumalis EA.J Crohns Colitis. 2010 Sep;4(3):349-50. doi: 10.1016/j.crohns.2010.05.005. Epub 2010 Jul 2.J Crohns Colitis2010Link
Pegylated interferon alfa-2b pen device and ribavirin treatment for patients with chronic hepatitis C: an evaluation of patient satisfactionAggelopoulou-Tiga P, Dimitroulopoulos D, Kaligeros K, Koutsounas S, Kouroumalis E, Diamanti H, Ionnidou P, Kountouras J, Papaioannou C, Dimopoulou M, Giannoulis G, Ketikoglou I, Protopapas A, Bassaris H, Delis V, Karatapanis S, Manolakopoulos S, Mimidis K, Nikolaou A, Thomopoulos K, Tzelas G, Tsianos E, Kardasi M, Perperas A.Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1058-65. doi: 10.1097/meg.0b013e3283399a1b.Eur J Gastroenterol Hepatol2010Link
A concentration-dependent effect of ursodeoxycholate on apoptosis and caspases activities of HepG2 hepatocellular carcinoma cellsTsagarakis NJ, Drygiannakis I, Batistakis AG, Kolios G, Kouroumalis EA.Eur J Pharmacol. 2010 Aug 25;640(1-3):1-7. doi: 10.1016/j.ejphar.2010.04.023. Epub 2010 May 6.Eur J Pharmacol2010Link
Serum TGF-beta2 and TGF-beta3 are increased and positively correlated to pain, functionality, and radiographic staging in osteoarthritisKapetanakis S, Drygiannakis I, Kazakos K, Papanas N, Kolios G, Kouroumalis E, Verettas DA.Orthopedics. 2010 Aug 11;33(8). doi: 10.3928/01477447-20100625-09.Orthopedics2010Link
Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel diseaseKoutroubakis IE, Oustamanolakis P, Karakoidas C, Mantzaris GJ, Kouroumalis EA.Dig Dis Sci. 2010 Aug;55(8):2327-31. doi: 10.1007/s10620-009-1022-y. Epub 2009 Oct 16.Dig Dis Sci2010Link
IBD: which patients with IBD are at risk of venous thromboembolism?Koutroubakis IE.Nat Rev Gastroenterol Hepatol. 2010 Jun;7(6):307-8. doi: 10.1038/nrgastro.2010.64.Nat Rev Gastroenterol Hepatol2010Link
Disease activity and venous thromboembolism in inflammatory bowel diseaseKoutroubakis IE, Pena AS.Lancet. 2010 May 15;375(9727):1689; author reply 1690-1. doi: 10.1016/S0140-6736(10)60727-1.Lancet2010Link
Recent advances in the management of distal ulcerative colitisKoutroubakis IE.World J Gastrointest Pharmacol Ther. 2010 Apr 6;1(2):43-50. doi: 10.4292/wjgpt.v1.i2.43.World J Gastrointest Pharmacol Ther2010Link
Anti-TNF and fistulizing perianal Crohn's disease: use in clinical practiceBourikas LA, Koutroubakis IE.Curr Drug Targets. 2010 Feb;11(2):187-97. doi: 10.2174/138945010790309966.Curr Drug Targets2010Link
Musculoskeletal manifestations of inflammatory bowel diseaseBourikas LA, Papadakis KA.Inflamm Bowel Dis. 2009 Dec;15(12):1915-24. doi: 10.1002/ibd.20942. Epub 2009 Apr 30.Inflamm Bowel Dis2009Link
Role of scintigraphy in inflammatory bowel diseaseStathaki MI, Koukouraki SI, Karkavitsas NS, Koutroubakis IE.World J Gastroenterol. 2009 Jun 14;15(22):2693-700. doi: 10.3748/wjg.15.2693.World J Gastroenterol2009Link
Ciprofloxacin decreases survival in HT-29 cells via the induction of TGF-beta1 secretion and enhances the anti-proliferative effect of 5-fluorouracilBourikas LA, Kolios G, Valatas V, Notas G, Drygiannakis I, Pelagiadis I, Manousou P, Klironomos S, Mouzas IA, Kouroumalis E.Br J Pharmacol. 2009 Jun;157(3):362-70. doi: 10.1111/j.1476-5381.2009.00161.x. Epub 2009 Apr 9.Br J Pharmacol2009Link
Oxidative stress due to anesthesia and surgical trauma: importance of early enteral nutritionKotzampassi K, Kolios G, Manousou P, Kazamias P, Paramythiotis D, Papavramidis TS, Heliadis S, Kouroumalis E, Eleftheriadis E.Mol Nutr Food Res. 2009 Jun;53(6):770-9. doi: 10.1002/mnfr.200800166.Mol Nutr Food Res2009Link
Effects of tumor necrosis factor alpha inhibition with infliximab on lipid levels and insulin resistance in patients with inflammatory bowel diseaseKoutroubakis IE, Oustamanolakis P, Malliaraki N, Karmiris K, Chalkiadakis I, Ganotakis E, Karkavitsas N, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2009 Mar;21(3):283-8. doi: 10.1097/MEG.0b013e328325d42b.Eur J Gastroenterol Hepatol2009Link
Progression of HCV infection in patients with chronic kidney diseaseCholongitas E, Manousou P, Samonakis D, Burroughs AK.J Hepatol. 2009 Mar;50(3):621-2; author reply 622. doi: 10.1016/j.jhep.2008.12.003. Epub 2008 Dec 16.J Hepatol2009Link
Crohn's disease lymphadenopathy: MR imaging findingsGourtsoyianni S, Papanikolaou N, Amanakis E, Bourikas L, Roussomoustakaki M, Grammatikakis J, Gourtsoyiannis N.Eur J Radiol. 2009 Mar;69(3):425-8. doi: 10.1016/j.ejrad.2008.11.009. Epub 2008 Dec 20.Eur J Radiol2009Link
Fatty acid composition of subcutaneous adipose tissue and gastric mucosa: is there a relation with gastric ulceration?Pagkalos VA, Moschandreas J, Kiriakakis M, Roussomoustakaki M, Kafatos A, Kouroumalis E.BMC Gastroenterol. 2009 Jan 23;9:9. doi: 10.1186/1471-230X-9-9.BMC Gastroenterol2009Link
Ischemic colitis: clinical practice in diagnosis and treatmentTheodoropoulou A, Koutroubakis IE.World J Gastroenterol. 2008 Dec 28;14(48):7302-8. doi: 10.3748/wjg.14.7302.World J Gastroenterol2008Link
Spectrum of non-inflammatory bowel disease and non-infectious colitisKoutroubakis IE.World J Gastroenterol. 2008 Dec 28;14(48):7277-9. doi: 10.3748/wjg.14.7277.World J Gastroenterol2008Link
Exploring the agreement between diagnostic criteria for IBS in primary care in GreeceAnastasiou F, Mouzas IA, Moschandreas J, Kouroumalis E, Lionis C.BMC Res Notes. 2008 Dec 3;1:127. doi: 10.1186/1756-0500-1-127.BMC Res Notes2008Link
Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interactionManousou P, Kolios G, Drygiannakis I, Pyrovolaki K, Bourikas L, Papadaki HA, Kouroumalis E.J Gastroenterol Hepatol. 2008 Dec;23(12):1823-33. doi: 10.1111/j.1440-1746.2008.05486.x. Epub 2008 Aug 28.J Gastroenterol Hepatol2008Link
Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cellsKolios G, Valatas V, Manousou P, Xidakis C, Notas G, Kouroumalis E.Mol Cell Biochem. 2008 Dec;319(1-2):91-8. doi: 10.1007/s11010-008-9881-7. Epub 2008 Jul 16.Mol Cell Biochem2008Link
Is there a role for Tc-99m (V) DMSA scintigraphy in ischemic colitis?Stathaki MI, Koutroubakis IE, Koukouraki SI, Kouroumalis EA, Karkavitsas NS.World J Gastroenterol. 2008 Sep 21;14(35):5432-5. doi: 10.3748/wjg.14.5432.World J Gastroenterol2008Link
Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel diseaseKoutroubakis IE, Sfiridaki A, Tsiolakidou G, Coucoutsi C, Theodoropoulou A, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2008 Sep;20(9):912-6. doi: 10.1097/MEG.0b013e3282faa759.Eur J Gastroenterol Hepatol2008Link
Venous thromboembolism in hospitalized inflammatory bowel disease patients: the magnitude of the problem is staggeringKoutroubakis IE.Am J Gastroenterol. 2008 Sep;103(9):2281-3. doi: 10.1111/j.1572-0241.2008.02060.x. Epub 2008 Aug 5.Am J Gastroenterol2008Link
Mannose-binding lectin MBL2 gene polymorphisms and outcome of hepatitis C virus-infected patientsKoutsounaki E, Goulielmos GN, Koulentaki M, Choulaki C, Kouroumalis E, Galanakis E.J Clin Immunol. 2008 Sep;28(5):495-500. doi: 10.1007/s10875-008-9201-8. Epub 2008 Jul 1.J Clin Immunol2008Link
Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well takenSamonakis DN, Notas G, Christodoulakis N, Kouroumalis EA.Dig Dis Sci. 2008 Sep;53(9):2359-65. doi: 10.1007/s10620-007-0175-9. Epub 2008 Feb 14.Dig Dis Sci2008Link
Genetic risk factors in young patients with ischemic colitisTheodoropoulou A, Sfiridaki A, Oustamanolakis P, Vardas E, Livadiotaki A, Boumpaki A, Paspatis G, Koutroubakis IE.Clin Gastroenterol Hepatol. 2008 Aug;6(8):907-11. doi: 10.1016/j.cgh.2008.03.010. Epub 2008 Jun 4.Clin Gastroenterol Hepatol2008Link
Leptin, adiponectin, resistin, and ghrelin--implications for inflammatory bowel diseaseKarmiris K, Koutroubakis IE, Kouroumalis EA.Mol Nutr Food Res. 2008 Aug;52(8):855-66. doi: 10.1002/mnfr.200700050.Mol Nutr Food Res2008Link
Increased expression of VEGF and CD146 in patients with inflammatory bowel diseaseTsiolakidou G, Koutroubakis IE, Tzardi M, Kouroumalis EA.Dig Liver Dis. 2008 Aug;40(8):673-9. doi: 10.1016/j.dld.2008.02.010. Epub 2008 Apr 18.Dig Liver Dis2008Link
Thrombosis and inflammatory bowel disease-the role of genetic risk factorsTsiolakidou G, Koutroubakis IE.World J Gastroenterol. 2008 Jul 28;14(28):4440-4. doi: 10.3748/wjg.14.4440.World J Gastroenterol2008Link
Disseminated tuberculosis in a Crohn's disease patient on anti-TNF alpha therapy despite chemoprophylaxisBourikas LA, Kourbeti IS, Koutsopoulos AV, Koutroubakis IE.Gut. 2008 Mar;57(3):425; author reply 425-6. doi: 10.1136/gut.2007.132407.Gut2008Link
Small bowel perforation due to non-Hodgkin-lymphoma in a patient with ulcerative colitis and systemic lupus erythematosusBourikas LA, Tzardi M, Hatzidakis A, Koutroubakis IE.Dig Liver Dis. 2008 Feb;40(2):144. doi: 10.1016/j.dld.2007.08.008. Epub 2007 Oct 22.Dig Liver Dis2008Link
Active inflammatory bowel disease: head-to-head comparison between 99mTc-hexamethylpropylene amine oxime white blood cells and 99mTc(V)-dimercaptosuccinic acid scintigraphyStathaki MI, Koutroubakis IE, Koukouraki SI, Karmiris KP, Moschandreas JA, Kouroumalis EA, Karkavitsas NS.Nucl Med Commun. 2008 Jan;29(1):27-32. doi: 10.1097/MNM.0b013e3282f1bc37.Nucl Med Commun2008Link
Resistin: another rising biomarker in inflammatory bowel disease?Karmiris K, Koutroubakis IE.Eur J Gastroenterol Hepatol. 2007 Dec;19(12):1035-7. doi: 10.1097/MEG.0b013e3282f16449.Eur J Gastroenterol Hepatol2007Link
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseasesGasche C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, Gomollon F, Hjortswang H, Koutroubakis I, Kulnigg S, Oldenburg B, Rampton D, Schroeder O, Stein J, Travis S, Van Assche G.Inflamm Bowel Dis. 2007 Dec;13(12):1545-53. doi: 10.1002/ibd.20285.Inflamm Bowel Dis2007Link
RT-PCR and immunocytochemistry studies support the presence of somatostatin, cortistatin and somatostatin receptor subtypes in rat Kupffer cellsXidakis C, Mastrodimou N, Notas G, Renieri E, Kolios G, Kouroumalis E, Thermos K.Regul Pept. 2007 Oct 4;143(1-3):76-82. doi: 10.1016/j.regpep.2007.03.005. Epub 2007 Mar 30.Regul Pept2007Link
Stimulating erythropoiesis in inflammatory bowel disease associated anemiaTsiolakidou G, Koutroubakis IE.World J Gastroenterol. 2007 Sep 28;13(36):4798-806. doi: 10.3748/wjg.v13.i36.4798.World J Gastroenterol2007Link
The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel diseaseKarmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2007 Sep;19(9):789-94. doi: 10.1097/MEG.0b013e3282202bca.Eur J Gastroenterol Hepatol2007Link
Enteral nutrition affects nitric oxide production in peripheral blood and liver after a postoperative lipopolysaccharide-induced endotoxemia in ratsKolios G, Kotzampassi K, Manousou P, Paramythiotis D, Papanastasiou H, Drygiannakis I, Notas G, Tsagarakis N, Eleftheriadis E, Kouroumalis E.Nutrition. 2007 Jul-Aug;23(7-8):575-81. doi: 10.1016/j.nut.2007.04.010. Epub 2007 Jun 7.Nutrition2007Link
Ethical issues in endoscopy: patient satisfaction, safety in elderly patients, palliation, and relations with industry. Second European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, July 2006Ladas SD, Novis B, Triantafyllou K, Schoefl R, Rokkas T, Stanciu C, Isaacs P, Willich SN, Ronn O, Dremel H, Livadas G, Egan BJ, Boyacioglu S, Selimovic A, Pulanic R, Karagiannis JA, Van Vooren JP, Kouroumalis E, O'Morain C, Nowak A, Deviere J, Malfertheiner P, Axon A.Endoscopy. 2007 Jun;39(6):556-65. doi: 10.1055/s-2007-966534.Endoscopy2007Link
Antibodies against cyclic citrullinated peptide (CCP) in inflammatory bowel disease patients with or without arthritic manifestationsKoutroubakis IE, Karmiris K, Bourikas L, Kouroumalis EA, Drygiannakis I, Drygiannakis D.Inflamm Bowel Dis. 2007 Apr;13(4):504-5. doi: 10.1002/ibd.20038.Inflamm Bowel Dis2007Link
Genetic risk factors in patients with inflammatory bowel disease and vascular complications: case-control studyKoutroubakis IE, Sfiridaki A, Tsiolakidou G, Theodoropoulou A, Livadiotaki A, Paspatis G, Kouroumalis EA.Inflamm Bowel Dis. 2007 Apr;13(4):410-5. doi: 10.1002/ibd.20076.Inflamm Bowel Dis2007Link
Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosisHöie O, Schouten LJ, Wolters FL, Solberg IC, Riis L, Mouzas IA, Politi P, Odes S, Langholz E, Vatn M, Stockbrügger RW, Moum B; European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD).Gut. 2007 Apr;56(4):497-503. doi: 10.1136/gut.2006.101519. Epub 2006 Oct 6.Gut2007Link
The patient with persistent perianal fistulaeKoutroubakis IE.Best Pract Res Clin Gastroenterol. 2007;21(3):503-18. doi: 10.1016/j.bpg.2007.04.002.Best Pract Res Clin Gastroenterol2007Link
Ileal malignant melanoma causing intussusception: report of a caseKarmiris K, Roussomoustakaki M, Tzardi M, Romanos J, Grammatikakis J, Papadakis M, Polychronaki M, Kouroumalis EA.Surg Today. 2007;37(6):506-9. doi: 10.1007/s00595-006-3443-y. Epub 2007 May 28.Surg Today2007Link
Role of Kupffer cells in the pathogenesis of liver diseaseKolios G, Valatas V, Kouroumalis E.World J Gastroenterol. 2006 Dec 14;12(46):7413-20. doi: 10.3748/wjg.v12.i46.7413.World J Gastroenterol2006Link
Ciprofloxacin inhibits cytokine-induced nitric oxide production in human colonic epitheliumKolios G, Manousou P, Bourikas L, Notas G, Tsagarakis N, Mouzas I, Kouroumalis E.Eur J Clin Invest. 2006 Oct;36(10):720-9. doi: 10.1111/j.1365-2362.2006.01710.x.Eur J Clin Invest2006Link
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluationOdes S, Vardi H, Friger M, Wolters F, Russel MG, Riis L, Munkholm P, Politi P, Tsianos E, Clofent J, Vermeire S, Monteiro E, Mouzas I, Fornaciari G, Sijbrandij J, Limonard C, Van Zeijl G, O'morain C, Moum B, Vatn M, Stockbrugger R; European Collaborative Study on Inflammatory Bowel Disease.Gastroenterology. 2006 Sep;131(3):719-28. doi: 10.1053/j.gastro.2006.05.052.Gastroenterology2006Link
Immunoproliferative small intestinal disease in Greece: presentation of 13 cases including two from AlbaniaEconomidou I, Manousos ON, Triantafillidis JK, Vaslamatzis MM, Zafiropoulou R, Papadakis T.Eur J Gastroenterol Hepatol. 2006 Sep;18(9):1029-38. doi: 10.1097/01.meg.0000228976.64774.04.Eur J Gastroenterol Hepatol2006Link
Factors associated with disease evolution in Greek patients with inflammatory bowel diseaseChatzicostas C, Roussomoustakaki M, Potamianos S, Paspatis G, Mouzas I, Romanos J, Mavrogeni H, Kouroumalis E.BMC Gastroenterol. 2006 Jul 25;6:21. doi: 10.1186/1471-230X-6-21.BMC Gastroenterol2006Link
Autoimmune cholangitis in twin sistersSamonakis DN, Chatzicostas C, Vardas E, Matrella E, Hatzidakis A, Kouroumalis EA.Acta Gastroenterol Belg. 2006 Jul-Sep;69(3):340-1.Acta Gastroenterol Belg2006Link
Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel diseaseRiis L, Vind I, Politi P, Wolters F, Vermeire S, Tsianos E, Freitas J, Mouzas I, Ruiz Ochoa V, O'Morain C, Odes S, Binder V, Moum B, Stockbrügger R, Langholz E, Munkholm P; European Collaborative study group on Inflammatory Bowel Disease.Am J Gastroenterol. 2006 Jul;101(7):1539-45. doi: 10.1111/j.1572-0241.2006.00602.x.Am J Gastroenterol2006Link
Role of angiogenesis in inflammatory bowel diseaseKoutroubakis IE, Tsiolakidou G, Karmiris K, Kouroumalis EA.Inflamm Bowel Dis. 2006 Jun;12(6):515-23. doi: 10.1097/00054725-200606000-00012.Inflamm Bowel Dis2006Link
Pathogenesis of primary biliary cirrhosis: a unifying modelKouroumalis E, Notas G.World J Gastroenterol. 2006 Apr 21;12(15):2320-7. doi: 10.3748/wjg.v12.i15.2320.World J Gastroenterol2006Link
Treatment of anaemia in inflammatory bowel diseaseKoutroubakis IE, Karmiris K, Kouroumalis EA.Aliment Pharmacol Ther. 2006 Apr 15;23(8):1273-4; author reply 1274-5. doi: 10.1111/j.1365-2036.2006.02807.x.Aliment Pharmacol Ther2006Link
Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot studyKoutroubakis IE, Karmiris K, Makreas S, Xidakis C, Niniraki M, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2006 Apr;18(4):421-5. doi: 10.1097/00042737-200604000-00017.Eur J Gastroenterol Hepatol2006Link
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohortWolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm P, Bodini P, O'Morain C, Mouzas IA, Tsianos E, Vermeire S, Monteiro E, Limonard C, Vatn M, Fornaciari G, Pereira S, Moum B, Stockbrügger RW; European Collaborative study group on Inflammatory Bowel Disease (EC-IBD).Gut. 2006 Apr;55(4):510-8. doi: 10.1136/gut.2005.072793. Epub 2005 Sep 8.Gut2006Link
European evidence based consensus on the diagnosis and management of Crohn's disease: special situationsCaprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar MM, Freitas JL, Mouzas IA, Baert F, Mitchell R, Hawkey CJ; European Crohn's and Colitis Organisation.Gut. 2006 Mar;55 Suppl 1(Suppl 1):i36-58. doi: 10.1136/gut.2005.081950c.Gut2006Link
Dermatological manifestations in primary biliary cirrhosis patients: a case control studyKoulentaki M, Ioannidou D, Stefanidou M, Maraki S, Drigiannakis I, Dimoulios P, Melono JM, Tosca A, Kouroumalis EA.Am J Gastroenterol. 2006 Mar;101(3):541-6. doi: 10.1111/j.1572-0241.2006.00423.x. Epub 2006 Feb 8.Am J Gastroenterol2006Link
Inherited thrombophilia and thrombosis in inflammatory bowel diseaseKoutroubakis IE, Tsiolakidou G, Kouroumalis EA.Am J Gastroenterol. 2006 Feb;101(2):403; author reply 403-4. doi: 10.1111/j.1572-0241.2006.00401_1.x.Am J Gastroenterol2006Link
Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel diseaseKoutroubakis IE, Xidakis C, Karmiris K, Sfiridaki A, Kandidaki E, Kouroumalis EA.Eur J Clin Invest. 2006 Feb;36(2):127-32. doi: 10.1111/j.1365-2362.2006.01602.x.Eur J Clin Invest2006Link
Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel diseaseKarmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA.Inflamm Bowel Dis. 2006 Feb;12(2):100-5. doi: 10.1097/01.MIB.0000200345.38837.46.Inflamm Bowel Dis2006Link
Octreotide for unresectable hepatocellular carcinoma: beyond the first sightSamonakis DN, Christodoulakis N, Kouroumalis EA.J Clin Gastroenterol. 2006 Jan;40(1):86-7. doi: 10.1097/01.mcg.0000190778.50279.26.J Clin Gastroenterol2006Link
Pancreatic autoantibodies in Greek patients with inflammatory bowel diseaseKoutroubakis IE, Drygiannakis D, Karmiris K, Drygiannakis I, Makreas S, Kouroumalis EA.Dig Dis Sci. 2005 Dec;50(12):2330-4. doi: 10.1007/s10620-005-3056-0.Dig Dis Sci2005Link
The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel diseaseKarmiris K, Koutroubakis IE, Kouroumalis EA.Inflamm Bowel Dis. 2005 Sep;11(9):847-55. doi: 10.1097/01.mib.0000178915.54264.8f.Inflamm Bowel Dis2005Link
Patients with primary biliary cirrhosis have increased serum total antioxidant capacity measured with the crocin bleaching assayNotas G, Miliaraki N, Kampa M, Dimoulios F, Matrella E, Hatzidakis A, Castanas E, Kouroumalis E.World J Gastroenterol. 2005 Jul 21;11(27):4194-8. doi: 10.3748/wjg.v11.i27.4194.World J Gastroenterol2005Link
Therapy insight: Vascular complications in patients with inflammatory bowel diseaseKoutroubakis IE.Nat Clin Pract Gastroenterol Hepatol. 2005 Jun;2(6):266-72. doi: 10.1038/ncpgasthep0190.Nat Clin Pract Gastroenterol Hepatol2005Link
Production of pro- and anti-fibrotic agents by rat Kupffer cells; the effect of octreotideXidakis C, Ljumovic D, Manousou P, Notas G, Valatas V, Kolios G, Kouroumalis E.Dig Dis Sci. 2005 May;50(5):935-41. doi: 10.1007/s10620-005-2668-8.Dig Dis Sci2005Link
Bile leakage presenting as acute abdomen due to a stone created around a migrated surgical clipMouzas IA, Petrakis I, Vardas E, Kogerakis N, Skordilis P, Prassopoulos P.Med Sci Monit. 2005 Mar;11(3):CS16-8.Med Sci Monit2005Link
Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosisDimoulios P, Kolios G, Notas G, Matrella E, Xidakis C, Koulentaki M, Tsagarakis N, Kouroumalis A, Kouroumalis E.Aliment Pharmacol Ther. 2005 Feb 1;21(3):227-34. doi: 10.1111/j.1365-2036.2005.02307.x.Aliment Pharmacol Ther2005Link
Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzleKolios G, Valatas V, Ward SG.Immunology. 2004 Dec;113(4):427-37. doi: 10.1111/j.1365-2567.2004.01984.x.Immunology2004Link
Serum angiogenin in inflammatory bowel diseaseKoutroubakis IE, Xidakis C, Karmiris K, Sfiridaki A, Kandidaki E, Kouroumalis EA.Dig Dis Sci. 2004 Nov-Dec;49(11-12):1758-62. doi: 10.1007/s10620-004-9565-4.Dig Dis Sci2004Link
Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel diseaseKoutroubakis IE, Theodoropoulou A, Xidakis C, Sfiridaki A, Notas G, Kolios G, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1147-52. doi: 10.1097/00042737-200411000-00011.Eur J Gastroenterol Hepatol2004Link
Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseasesLjumovic D, Diamantis I, Alegakis AK, Kouroumalis EA.Clin Chim Acta. 2004 Nov;349(1-2):203-11. doi: 10.1016/j.cccn.2004.06.028.Clin Chim Acta2004Link
Short questionnaire based on IBDQMouzas IA, Pallis AG.Am J Gastroenterol. 2004 Oct;99(10):2068; author reply 2068-9. doi: 10.1111/j.1572-0241.2004.40680_4.x.Am J Gastroenterol2004Link
Decreased total and corrected antioxidant capacity in patients with inflammatory bowel diseaseKoutroubakis IE, Malliaraki N, Dimoulios PD, Karmiris K, Castanas E, Kouroumalis EA.Dig Dis Sci. 2004 Sep;49(9):1433-7. doi: 10.1023/b:ddas.0000042242.22898.d9.Dig Dis Sci2004Link
Secretion of inflammatory mediators by isolated rat Kupffer cells: the effect of octreotideValatas V, Kolios G, Manousou P, Xidakis C, Notas G, Ljumovic D, Kouroumalis EA.Regul Pept. 2004 Aug 15;120(1-3):215-25. doi: 10.1016/j.regpep.2004.03.009.Regul Pept2004Link
Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatmentKoulentaki M, Moscandrea J, Dimoulios P, Chatzicostas C, Kouroumalis EA.Dig Dis Sci. 2004 Aug;49(7-8):1190-5. doi: 10.1023/b:ddas.0000037811.48575.da.Dig Dis Sci2004Link
The inflammatory bowel disease questionnaire: a review of its national validation studiesPallis AG, Mouzas IA, Vlachonikolis IG.Inflamm Bowel Dis. 2004 May;10(3):261-9. doi: 10.1097/00054725-200405000-00014.Inflamm Bowel Dis2004Link
Instruments for quality of life assessment in patients with gastrointestinal cancerPallis AG, Mouzas IA.Anticancer Res. 2004 May-Jun;24(3b):2117-21.Anticancer Res2004Link
Hypercoagulable states in patients with hepatocellular carcinomaSamonakis DN, Koutroubakis IE, Sfiridaki A, Malliaraki N, Antoniou P, Romanos J, Kouroumalis EA.Dig Dis Sci. 2004 May;49(5):854-8. doi: 10.1023/b:ddas.0000030099.13397.28.Dig Dis Sci2004Link
Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptorsNotas G, Kolios G, Mastrodimou N, Kampa M, Vasilaki A, Xidakis C, Castanas E, Thermos K, Kouroumalis E.J Hepatol. 2004 May;40(5):792-8. doi: 10.1016/j.jhep.2004.01.016.J Hepatol2004Link
Treatment of oesophageal Crohn's disease with infliximabTheodoropoulou A, Koutroubakis IE, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2004 Apr;16(4):431-2. doi: 10.1097/00042737-200404000-00013.Eur J Gastroenterol Hepatol2004Link
Effect of octreotide on apoptosis-related proteins in rat Kupffer cells: a possible anti-tumour mechanismXidakis C, Kolios G, Valatas V, Notas G, Mouzas I, Kouroumalis E.Anticancer Res. 2004 Mar-Apr;24(2B):833-41.Anticancer Res2004Link
Binge drinking and nitric oxide metabolites in chronic liver diseaseOekonomaki E, Notas G, Mouzas IA, Valatas V, Skordilis P, Xidakis C, Kouroumalis EA.Alcohol Alcohol. 2004 Mar-Apr;39(2):106-9. doi: 10.1093/alcalc/agh030.Alcohol Alcohol2004Link
Nitric oxide and pro-inflammatory cytokines in acute hepatitis BKoulentaki M, Notas G, Petinaki E, Valatas V, Mouzas IA, Castanas E, Kouroumalis EA.Eur J Intern Med. 2004 Feb;15(1):35-38. doi: 10.1016/j.ejim.2003.11.004.Eur J Intern Med2004Link
Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cellsValatas V, Kolios G, Manousou P, Notas G, Xidakis C, Diamantis I, Kouroumalis E.Br J Pharmacol. 2004 Feb;141(3):477-87. doi: 10.1038/sj.bjp.0705633. Epub 2004 Jan 12.Br J Pharmacol2004Link
Serum laminin and collagen IV in inflammatory bowel diseaseKoutroubakis IE, Petinaki E, Dimoulios P, Vardas E, Roussomoustakaki M, Maniatis AN, Kouroumalis EA.J Clin Pathol. 2003 Nov;56(11):817-20. doi: 10.1136/jcp.56.11.817.J Clin Pathol2003Link
Active inflammatory bowel disease: evaluation with 99mTc (V) DMSA scintigraphyKoutroubakis IE, Koukouraki SI, Dimoulios PD, Velidaki AA, Karkavitsas NS, Kouroumalis EA.Radiology. 2003 Oct;229(1):70-4. doi: 10.1148/radiol.2291020692. Epub 2003 Aug 18.Radiology2003Link
Low plasma protein Z levels in patients with ischemic colitisKoutroubakis IE, Theodoropoulou A, Sfiridaki A, Kouroumalis EA.Dig Dis Sci. 2003 Sep;48(9):1673-6. doi: 10.1023/a:1025441405688.Dig Dis Sci2003Link
Recommendations of the ESGE workshop on the Ethics of Percutaneous Endoscopic Gastrostomy (PEG) Placement for Nutritional Support. First European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, June 2003Kruse A, Misiewicz JJ, Rokkas T, Hammer H, Niv Y, Allison M, Kouroumalis E, Campbell D.Endoscopy. 2003 Sep;35(9):778-80. doi: 10.1055/s-2003-41589.Endoscopy2003Link
Complete regression of primary gastric plasmacytoma following Helicobacter pylori eradicationPapadaki HA, Skordilis P, Minadakis G, Roussomoustakaki M, Katrinakis G, Psyllaki M, Tzardi M, Kouroumalis E, Eliopoulos GD.Ann Hematol. 2003 Sep;82(9):589-92. doi: 10.1007/s00277-003-0701-6. Epub 2003 Jul 24.Ann Hematol2003Link
A case of sigmoid endometriosis difficult to differentiate from colon cancerDimoulios P, Koutroubakis IE, Tzardi M, Antoniou P, Matalliotakis IM, Kouroumalis EA.BMC Gastroenterol. 2003 Aug 7;3:18. doi: 10.1186/1471-230X-3-18.BMC Gastroenterol2003Link
Improved validation of the Inflammatory Bowel Disease Questionnaire and development of a short form in Greek patientsVlachonikolis IG, Pallis AG, Mouzas IA.Am J Gastroenterol. 2003 Aug;98(8):1802-12. doi: 10.1111/j.1572-0241.2003.07518.x.Am J Gastroenterol2003Link
Intestinal metaplasia of cardiac mucosa and its immunostaining characteristicsMouzas IA, Jovanovic I.Am J Gastroenterol. 2003 Jul;98(7):1653-4; author reply 1654-6. doi: 10.1111/j.1572-0241.2003.07572.x.Am J Gastroenterol2003Link
Transient ischaemic colitis following an aeroplane flightKoutroubakis IE, Theodoropoulou A, Kouroumalis EA.Gut. 2003 Jul;52(7):1072-3. doi: 10.1136/gut.52.7.1072-a.Gut2003Link
A comparison of Child-Pugh, APACHE II and APACHE III scoring systems in predicting hospital mortality of patients with liver cirrhosisChatzicostas C, Roussomoustakaki M, Notas G, Vlachonikolis IG, Samonakis D, Romanos J, Vardas E, Kouroumalis EA.BMC Gastroenterol. 2003 May 8;3:7. doi: 10.1186/1471-230X-3-7.BMC Gastroenterol2003Link
Increased serum levels of YKL-40 in patients with inflammatory bowel diseaseKoutroubakis IE, Petinaki E, Dimoulios P, Vardas E, Roussomoustakaki M, Maniatis AN, Kouroumalis EA.Int J Colorectal Dis. 2003 May;18(3):254-9. doi: 10.1007/s00384-002-0446-z. Epub 2002 Nov 30.Int J Colorectal Dis2003Link
Increased incidence of fungal infections in advanced primary biliary cirrhosisSamonakis DN, Chatzicostas C, Vardas E, Roussomoustakaki M, Kouroumalis EA.J Clin Gastroenterol. 2003 Apr;36(4):369. doi: 10.1097/00004836-200304000-00019.J Clin Gastroenterol2003Link
Balthazar computed tomography severity index is superior to Ranson criteria and APACHE II and III scoring systems in predicting acute pancreatitis outcomeChatzicostas C, Roussomoustakaki M, Vardas E, Romanos J, Kouroumalis EA.J Clin Gastroenterol. 2003 Mar;36(3):253-60. doi: 10.1097/00004836-200303000-00013.J Clin Gastroenterol2003Link
Octreotide treatment of hepatocellular carcinomaKouroumalis E, Samonakis D, Skordilis P.Hepatology. 2003 Feb;37(2):477. doi: 10.1053/jhep.2003.50026.Hepatology2003Link
Validation of a reliable instrument (QUOTE-IBD) for assessing the quality of health care in Greek patients with inflammatory bowel diseasePallis AG, Vlachonikolis IG, Mouzas IA.Digestion. 2003;68(2-3):153-60. doi: 10.1159/000075524. Epub 2003 Dec 10.Digestion2003Link
Hidradenitis suppurativa associated with Crohn's disease and spondyloarthropathy: response to anti-TNF therapyRoussomoustakaki M, Dimoulios P, Chatzicostas C, Kritikos HD, Romanos J, Panayiotides JG, Kouroumalis EA.J Gastroenterol. 2003;38(10):1000-4. doi: 10.1007/s00535-003-1185-9.J Gastroenterol2003Link
Isolation of rat Kupffer cells: a combined methodology for highly purified primary culturesValatas V, Xidakis C, Roumpaki H, Kolios G, Kouroumalis EA.Cell Biol Int. 2003;27(1):67-73. doi: 10.1016/s1065-6995(02)00249-4.Cell Biol Int2003Link
Urocortin in human gastric mucosa: relationship to inflammatory activityChatzaki E, Charalampopoulos I, Leontidis C, Mouzas IA, Tzardi M, Tsatsanis C, Margioris AN, Gravanis A.J Clin Endocrinol Metab. 2003 Jan;88(1):478-83. doi: 10.1210/jc.2002-020853.J Clin Endocrinol Metab2003Link
NOD2 insertion mutation in a Cretan Crohn's disease populationRoussomoustakaki M, Koutroubakis I, Vardas EM, Dimoulios P, Kouroumalis EA, Baritaki S, Koutsoudakis G, Krambovitis E.Gastroenterology. 2003 Jan;124(1):272-3; author reply 273-4. doi: 10.1053/gast.2003.50036.Gastroenterology2003Link
Acquired inhibitors to coagulation factors in patients with gastrointestinal diseasesKyriakou DS, Alexandrakis MG, Passam FH, Foundouli K, Matalliotakis E, Koutroubakis IE, Kourelis TV, Chalkiadakis G, Manoussos ON.Eur J Gastroenterol Hepatol. 2002 Dec;14(12):1383-7. doi: 10.1097/00042737-200212000-00016.Eur J Gastroenterol Hepatol2002Link
Cytokeratin immunoreactivity of intestinal metaplasiaMouzas IA, Jovanovic I, Milosavljevic T, Tzardi M, Kanavaros P.Gut. 2002 Dec;51(6):894-5; author reply 895. doi: 10.1136/gut.51.6.894-a.Gut2002Link
Increasing incidence of cholangiocarcinoma in Crete 1992-2000Mouzas IA, Dimoulios P, Vlachonikolis IG, Skordilis P, Zoras O, Kouroumalis E.Anticancer Res. 2002 Nov-Dec;22(6B):3637-41.Anticancer Res2002Link
Autonomic imbalance during the day in patients with inflammatory bowel disease in remission. Evidence from spectral analysis of heart rate variability over 24 hoursMouzas IA, Pallis AG, Kochiadakis GE, Marketou M, Chlouverakis GI, Mellisas J, Vardas PE, Kouroumalis EA.Dig Liver Dis. 2002 Nov;34(11):775-80. doi: 10.1016/s1590-8658(02)80070-6.Dig Liver Dis2002Link
Comparison of Ranson, APACHE II and APACHE III scoring systems in acute pancreatitisChatzicostas C, Roussomoustakaki M, Vlachonikolis IG, Notas G, Mouzas I, Samonakis D, Kouroumalis EA.Pancreas. 2002 Nov;25(4):331-5. doi: 10.1097/00006676-200211000-00002.Pancreas2002Link
Optimization of a contrast medium suitable for conventional enteroclysis, MR enteroclysis, and virtual MR enteroscopyPapanikolaou N, Prassopoulos P, Grammatikakis J, Maris T, Kouroumalis E, Gourtsoyiannis N.Abdom Imaging. 2002 Sep-Oct;27(5):517-22. doi: 10.1007/s00261-001-0179-4.Abdom Imaging2002Link
(99m)Tc-Leucoscan in the evaluation of inflammatory bowel diseaseKapsoritakis AN, Koutroubakis IE, Kouroumalis EA, Koukouraki SI, Karkavitsas N.Eur J Nucl Med Mol Imaging. 2002 Aug;29(8):1098. doi: 10.1007/s00259-002-0855-9.Eur J Nucl Med Mol Imaging2002Link
Unexpected toxicity after low-dose docetaxel treatment of a cancer patient with clinically latent HCV-positive hepatic cirrhosisKoukourakis MI, Kapsoritakis A, Maltezos E, Potamiano S, Mouzas I, Kouroumalis H.Anticancer Res. 2002 Jul-Aug;22(4):2491-2.Anticancer Res2002Link
Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical reviewKoutroubakis IE, Vlachonikolis IG, Kouroumalis EA.Inflamm Bowel Dis. 2002 Jul;8(4):277-86. doi: 10.1097/00054725-200207000-00007.Inflamm Bowel Dis2002Link
Treatment of hepatocellular carcinoma with long acting somatostatin analoguesSamonakis DN, Moschandreas J, Arnaoutis T, Skordilis P, Leontidis C, Vafiades I, Kouroumalis E.Oncol Rep. 2002 Jul-Aug;9(4):903-7.Oncol Rep2002Link
Validation and results of a questionnaire for functional bowel disease in out-patientsMouzas IA, Fragkiadakis N, Moschandreas J, Karachristos A, Skordilis P, Kouroumalis E, Manousos ON.BMC Public Health. 2002 May 21;2:8. doi: 10.1186/1471-2458-2-8.BMC Public Health2002Link
Colonic tuberculosis mimicking Crohn's disease: case reportChatzicostas C, Koutroubakis IE, Tzardi M, Roussomoustakaki M, Prassopoulos P, Kouroumalis EA.BMC Gastroenterol. 2002 May 13;2:10. doi: 10.1186/1471-230x-2-10.BMC Gastroenterol2002Link
Matrix metalloproteinases and their inhibitors in acute viral hepatitisKoulentaki M, Valatas V, Xidakis K, Kouroumalis A, Petinaki E, Castanas E, Kouroumalis E.J Viral Hepat. 2002 May;9(3):189-93. doi: 10.1046/j.1365-2893.2002.00351.x.J Viral Hepat2002Link
Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junctionJovanovic I, Tzardi M, Mouzas IA, Micev M, Pesko P, Milosavljevic T, Zois M, Sganzos M, Delides G, Kanavaros P.Histol Histopathol. 2002 Apr;17(2):445-54. doi: 10.14670/HH-17.445.Histol Histopathol2002Link
Depletion of non specific esterase activity in the colonic mucosa of patients with ulcerative colitisKolios G, Valatas V, Psilopoulos D, Petraki K, Kouroumalis E.Eur J Clin Invest. 2002 Apr;32(4):265-73. doi: 10.1046/j.1365-2362.2002.00969.x.Eur J Clin Invest2002Link
Circulating soluble vascular adhesion protein 1 in patients with inflammatory bowel diseaseKoutroubakis IE, Petinaki E, Vardas E, Dimoulios P, Roussomoustakaki M, Maniatis AN, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2002 Apr;14(4):405-8. doi: 10.1097/00042737-200204000-00012.Eur J Gastroenterol Hepatol2002Link
Apoptosis and apoptosis related proteins in chronic viral liver diseasePapakyriakou P, Tzardi M, Valatas V, Kanavaros P, Karydi E, Notas G, Xidakis C, Kouroumalis E.Apoptosis. 2002 Apr;7(2):133-41. doi: 10.1023/a:1014472430976.Apoptosis2002Link
Is endosonography an effective method for detection and local staging of the ampullary carcinoma? A prospective studySkordilis P, Mouzas IA, Dimoulios PD, Alexandrakis G, Moschandrea J, Kouroumalis E.BMC Surg. 2002 Mar 25;2:1. doi: 10.1186/1471-2482-2-1.BMC Surg2002Link
Fatal hepatic abscess caused by a fish boneTheodoropoulou A, Roussomoustakaki M, Michalodimitrakis MN, Kanaki C, Kouroumalis EA.Lancet. 2002 Mar 16;359(9310):977. doi: 10.1016/S0140-6736(02)07999-0.Lancet2002Link
Acquired and hereditary thrombotic risk factors in patients with acute mesenteric vein thrombosisDimoulios P, Koutroubakis IE, Sfiridaki A, Theodoropoulou A, Kouroumalis EA.Am J Gastroenterol. 2002 Mar;97(3):768-9. doi: 10.1111/j.1572-0241.2002.05575.x.Am J Gastroenterol2002Link
Diminutive polyps of large bowel should be an early target for endoscopic treatmentKapsoritakis AN, Potamianos SP, Koukourakis MI, Tzardi M, Mouzas IA, Roussomoustakaki M, Alexandrakis G, Kouroumalis EA.Dig Liver Dis. 2002 Feb;34(2):137-40. doi: 10.1016/s1590-8658(02)80244-4.Dig Liver Dis2002Link
Primary biliary cirrhosis and autoimmune cholangitis are not associated with coeliac disease in CreteChatzicostas C, Roussomoustakaki M, Drygiannakis D, Niniraki M, Tzardi M, Koulentaki M, Dimoulios P, Mouzas I, Kouroumalis E.BMC Gastroenterol. 2002;2:5. doi: 10.1186/1471-230x-2-5. Epub 2002 Mar 14.BMC Gastroenterol2002Link
Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, GreecePallis AG, Vlachonikolis IG, Mouzas IA.BMC Gastroenterol. 2002;2:1. doi: 10.1186/1471-230x-2-1. Epub 2002 Jan 10.BMC Gastroenterol2002Link
Increased levels of lipoprotein (a) in Crohn's disease: a relation to thrombosis?Koutroubakis IE, Malliaraki N, Vardas E, Ganotakis E, Margioris AN, Manousos ON, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1415-9. doi: 10.1097/00042737-200112000-00004.Eur J Gastroenterol Hepatol2001Link
Retroperitoneal fibrosis during the course of ulcerative colitis. A simple coincidence?Mouzas IA, Anezinis P, Karampekios S, Matrella E, Koulentaki M, Kouroumalis EA.Dig Liver Dis. 2001 Oct;33(7):587-90. doi: 10.1016/s1590-8658(01)80112-2.Dig Liver Dis2001Link
Role of acquired and hereditary thrombotic risk factors in colon ischemia of ambulatory patientsKoutroubakis IE, Sfiridaki A, Theodoropoulou A, Kouroumalis EA.Gastroenterology. 2001 Sep;121(3):561-5. doi: 10.1053/gast.2001.27227.Gastroenterology2001Link
Epidemiology of inflammatory bowel disease in Heraklion, CreteVlachonikolis IG, Koutroubakis IE, Manousos ON.Scand J Gastroenterol. 2001 Sep;36(9):1008.Scand J Gastroenterol2001Link
NS5A mutations predict biochemical but not virological response to interferon-alpha treatment of sporadic hepatitis C virus infection in European patientsStratidaki I, Skoulika E, Kelefiotis D, Matrella E, Alexandrakis G, Economou A, Kouroumalis E.J Viral Hepat. 2001 Jul;8(4):243-8. doi: 10.1046/j.1365-2893.2001.00294.x.J Viral Hepat2001Link
Hepatitis B and C markers in a Kurdish refugee camp in GreeceSkliros E, Lionis C, Foudoulaki L, Sotiropoulos A, Kouroumalis E, Spandidos D.J Gastroenterol Hepatol. 2001 Jul;16(7):839-40. doi: 10.1046/j.1440-1746.2001.02517.x.J Gastroenterol Hepatol2001Link
Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO-independent mechanism in chronic liver diseaseMatrella E, Valatas V, Notas G, Roumpaki H, Xidakis C, Hadzidakis A, Mouzas I, Kouroumalis E.Aliment Pharmacol Ther. 2001 Jun;15(6):857-64. doi: 10.1046/j.1365-2036.2001.00996.x.Aliment Pharmacol Ther2001Link
Unraveling the mechanisms of thrombosis in inflammatory bowel diseaseKoutroubakis IE.Am J Gastroenterol. 2001 May;96(5):1325-7. doi: 10.1111/j.1572-0241.2001.03846.x.Am J Gastroenterol2001Link
Prospective evaluation of the impact of amoxicillin, clarithromycin and their combination on human gastrointestinal colonization by Candida speciesMaraki S, Mouzas IA, Kontoyiannis DP, Chatzinikolaou I, Tselentis Y, Samonis G.Chemotherapy. 2001 May-Jun;47(3):215-8. doi: 10.1159/000063224.Chemotherapy2001Link
Mean platelet volume: a useful marker of inflammatory bowel disease activityKapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, Kouroumalis EA.Am J Gastroenterol. 2001 Mar;96(3):776-81. doi: 10.1111/j.1572-0241.2001.03621.x.Am J Gastroenterol2001Link
Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel diseaseKoutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis EA.Am J Gastroenterol. 2001 Feb;96(2):449-54. doi: 10.1111/j.1572-0241.2001.03524.x.Am J Gastroenterol2001Link
Prevalence of hepatitis B and C markers in high-risk hospitalised patients in Crete: a five-year observational studyKoulentaki M, Ergazaki M, Moschandrea J, Spanoudakis S, Tzagarakis N, Drandakis PE, Spandidos DA, Kouroumalis EA.BMC Public Health. 2001;1:17. doi: 10.1186/1471-2458-1-17. Epub 2001 Dec 21.BMC Public Health2001Link
Quality of life of Greek patients with inflammatory bowel disease. Validation of the Greek translation of the inflammatory bowel disease questionnairePallis AG, Vlachonikolis IG, Mouzas IA.Digestion. 2001;63(4):240-6. doi: 10.1159/000051896.Digestion2001Link
Low prevalence of liver-kidney microsomal autoantibodies of type 1 (LKM1) in hepatitis C seropositive subjects on Crete, GreeceDrygiannakis D, Lionis C, Drygiannakis I, Pappas G, Kouroumalis E.BMC Gastroenterol. 2001;1:4. doi: 10.1186/1471-230x-1-4. Epub 2001 Jun 11.BMC Gastroenterol2001Link
Mixed hyperplastic adenomatous polyps: neoplastic transformation of hyperplastic colorectal polyps?Kapsoritakis AN, Potamianos SP, Kouroumalis EA.Dig Liver Dis. 2001 Jan-Feb;33(1):85. doi: 10.1016/s1590-8658(01)80143-2.Dig Liver Dis2001Link
Use of a variety of biological parameters in distinguishing cirrhotic from malignant ascitesAlexandrakis MG, Moschandrea J, Kyriakou DS, Alexandraki R, Kouroumalis E.Int J Biol Markers. 2001 Jan-Mar;16(1):45-9.Int J Biol Markers2001Link
Octreotide for cancer of the liver and biliary treeKouroumalis EA.Chemotherapy. 2001;47 Suppl 2:150-61. doi: 10.1159/000049167.Chemotherapy2001Link
Levels of circulating endothelin-1 and nitrates/nitrites in patients with virus-related hepatocellular carcinomaNotas G, Xidakis C, Valatas V, Kouroumalis A, Kouroumalis E.J Viral Hepat. 2001 Jan;8(1):63-9. doi: 10.1046/j.1365-2893.2001.00269.x.J Viral Hepat2001Link
Hyperhomocysteinemia in Greek patients with inflammatory bowel diseaseKoutroubakis IE, Dilaveraki E, Vlachonikolis IG, Vardas E, Vrentzos G, Ganotakis E, Mouzas IA, Gravanis A, Emmanouel D, Kouroumalis EA.Dig Dis Sci. 2000 Dec;45(12):2347-51. doi: 10.1023/a:1005583606647.Dig Dis Sci2000Link
Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)Witte J, Shivananda S, Lennard-Jones JE, Beltrami M, Politi P, Bonanomi A, Tsianos EV, Mouzas I, Schulz TB, Monteiro E, Clofent J, Odes S, Limonard CB, Stockbrügger RW, Russel MG.Scand J Gastroenterol. 2000 Dec;35(12):1272-7. doi: 10.1080/003655200453610.Scand J Gastroenterol2000Link
Elevated thrombopoietin serum levels in patients with inflammatory bowel diseaseKapsoritakis AN, Potamianos SP, Sfiridaki AI, Koukourakis MI, Koutroubakis IE, Roussomoustakaki MI, Manousos ON, Kouroumalis EA.Am J Gastroenterol. 2000 Dec;95(12):3478-81. doi: 10.1111/j.1572-0241.2000.03364.x.Am J Gastroenterol2000Link
Instruments for quality of life assessment in patients with inflammatory bowel diseasePallis AG, Mouzas IA.Dig Liver Dis. 2000 Nov;32(8):682-8. doi: 10.1016/s1590-8658(00)80330-8.Dig Liver Dis2000Link
An epidemiological study of acute upper gastrointestinal bleeding in Crete, GreecePaspatis GA, Matrella E, Kapsoritakis A, Leontithis C, Papanikolaou N, Chlouverakis GJ, Kouroumalis E.Eur J Gastroenterol Hepatol. 2000 Nov;12(11):1215-20. doi: 10.1097/00042737-200012110-00008.Eur J Gastroenterol Hepatol2000Link
Idiopathic fibrosing pancreatitis and Crohn's disease: an interesting associationPotamianos S, Koutroubakis IE, Chatzicostas C, Rolles K, Burroughs AK, Kouroumalis EA.Eur J Gastroenterol Hepatol. 2000 Sep;12(9):1021-4. doi: 10.1097/00042737-200012090-00010.Eur J Gastroenterol Hepatol2000Link
Do undefined sources of hepatitis C transmission exist? The Greek study in General PracticeLionis C, Vlachonikolis IG, Skliros S, Symeonidis A, Merkouris BP, Kouroumalis E.J Viral Hepat. 2000 May;7(3):218-24. doi: 10.1046/j.1365-2893.2000.00217.x.J Viral Hepat2000Link
Discrimination between malignant and nonmalignant ascites using serum and ascitic fluid proteins in a multivariate analysis modelAlexandrakis MG, Moschandrea JA, Koulocheri SA, Kouroumalis E, Eliopoulos GD.Dig Dis Sci. 2000 Mar;45(3):500-8. doi: 10.1023/a:1005437005811.Dig Dis Sci2000Link
Role of thrombotic vascular risk factors in inflammatory bowel diseaseKoutroubakis IE.Dig Dis. 2000;18(3):161-7. doi: 10.1159/000051389.Dig Dis2000Link
Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel diseaseKoutroubakis IE, Sfiridaki A, Mouzas IA, Maladaki A, Kapsoritakis A, Roussomoustakaki M, Kouroumalis EA, Manousos ON.Am J Gastroenterol. 2000 Jan;95(1):190-4. doi: 10.1111/j.1572-0241.2000.01683.x.Am J Gastroenterol2000Link
Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studiesKoutroubakis IE, Vlachonikolis IG.Am J Gastroenterol. 2000 Jan;95(1):171-6. doi: 10.1111/j.1572-0241.2000.01680.x.Am J Gastroenterol2000Link
Core mental state in irritable bowel syndromeTrikas P, Vlachonikolis I, Fragkiadakis N, Vasilakis S, Manousos O, Paritsis N.Psychosom Med. 1999 Nov-Dec;61(6):781-8. doi: 10.1097/00006842-199911000-00010.Psychosom Med1999Link
Ulcerative colitis associated with primary biliary cirrhosisKoulentaki M, Koutroubakis IE, Petinaki E, Tzardi M, Oekonomaki H, Mouzas I, Kouroumalis EA.Dig Dis Sci. 1999 Oct;44(10):1953-6. doi: 10.1023/a:1026697613173.Dig Dis Sci1999Link
IGF-I and IGF-II in relation to colorectal cancerManousos O, Souglakos J, Bosetti C, Tzonou A, Chatzidakis V, Trichopoulos D, Adami HO, Mantzoros C.Int J Cancer. 1999 Sep 24;83(1):15-7. doi: 10.1002/(sici)1097-0215(19990924)83:1<15::aid-ijc4>3.0.co;2-y.Int J Cancer1999Link
Carcinoma of the ampulla of Vater in Crete. A clinical and ERCP registry over eight yearsMouzas IA, Skordilis P, Frangiadakis N, Leondidis C, Alexandrakis G, Potamianos S, Kouroumalis E, Manousos ON.Anticancer Res. 1999 Sep-Oct;19(5C):4501-5.Anticancer Res1999Link
Helicobacter pylori-associated protein-losing hypertrophic gastropathy with hypercholesterolemiaKapsoritakis AN, Potamianos S, Matrella E, Koukouraki S, Oeconomaki E, Tzardi M, Karkavitsas N, Kouroumalis EA.Dig Dis Sci. 1999 Sep;44(9):1843-7. doi: 10.1023/a:1018894723226.Dig Dis Sci1999Link
Prevalence of hepatitis B and C markers in volunteer blood donors in Crete. A 5-year studyKoulentaki M, Spanoudakis S, Kantidaki E, Drandakis P, Tzagarakis N, Biziagos E, Moschandrea J, Kouroumalis EA.J Viral Hepat. 1999 May;6(3):243-8. doi: 10.1046/j.1365-2893.1999.00155.x.J Viral Hepat1999Link
Death related to midazolam overdose during endoscopic retrograde cholangiopancreatographyMichalodimitrakis M, Christodoulou P, Tsatsakis AM, Askoxilakis I, Stiakakis I, Mouzas I.Am J Forensic Med Pathol. 1999 Mar;20(1):93-7. doi: 10.1097/00000433-199903000-00022.Am J Forensic Med Pathol1999Link
How Greek GPs manage hepatitis C infected patients: experiences gained from a primary health care district in rural CreteLionis C, Frangoulis E, Skliros S, Alexandrakis E, Kouroumalis E.Aust Fam Physician. 1999 Mar;28(3):207.Aust Fam Physician1999Link
Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: case-controlled study in CreteKoutroubakis IE, Vlachonikolis IG, Kapsoritakis A, Spanoudakis S, Roussomoustakaki M, Mouzas IA, Kouroumalis EA, Manousos ON.Dis Colon Rectum. 1999 Feb;42(2):225-30. doi: 10.1007/BF02237133.Dis Colon Rectum1999Link
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel diseaseKoutroubakis IE, Petinaki E, Anagnostopoulou E, Kritikos H, Mouzas IA, Kouroumalis EA, Manousos ON.Dig Dis Sci. 1998 Nov;43(11):2507-12. doi: 10.1023/a:1026602803622.Dig Dis Sci1998Link
Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folateMouzas IA, Papavassiliou E, Koutroubakis I.Ital J Gastroenterol Hepatol. 1998 Aug;30(4):421-5.Ital J Gastroenterol Hepatol1998Link
Somatostatin for acute severe bleeding from portal hypertensive gastropathyKouroumalis EA, Koutroubakis IE, Manousos ON.Eur J Gastroenterol Hepatol. 1998 Jun;10(6):509-12. doi: 10.1097/00042737-199806000-00013.Eur J Gastroenterol Hepatol1998Link
Association between ulcerative colitis and systemic lupus erythematosus: report of two casesKoutroubakis IE, Kritikos H, Mouzas IA, Spanoudakis SM, Kapsoritakis AN, Petinaki E, Kouroumalis EA, Manousos ON.Eur J Gastroenterol Hepatol. 1998 May;10(5):437-9. doi: 10.1097/00042737-199805000-00016.Eur J Gastroenterol Hepatol1998Link
Lung function in patients with inflammatory bowel diseaseTzanakis N, Bouros D, Samiou M, Panagou P, Mouzas J, Manousos O, Siafakas N.Respir Med. 1998 Mar;92(3):516-22. doi: 10.1016/s0954-6111(98)90301-8.Respir Med1998Link
Treatment of hepatocellular carcinoma with octreotide: a randomised controlled studyKouroumalis E, Skordilis P, Thermos K, Vasilaki A, Moschandrea J, Manousos ON.Gut. 1998 Mar;42(3):442-7. doi: 10.1136/gut.42.3.442.Gut1998Link
Small airways function in patients with inflammatory bowel diseaseTzanakis N, Samiou M, Bouros D, Mouzas J, Kouroumalis E, Siafakas NM.Am J Respir Crit Care Med. 1998 Feb;157(2):382-6. doi: 10.1164/ajrccm.157.2.97-04075.Am J Respir Crit Care Med1998Link
Systemic mastocytosis: a rare cause of noncirrhotic portal hypertension simulating autoimmune cholangitis--report of four casesKyriakou D, Kouroumalis E, Konsolas J, Oekonomaki H, Tzardi M, Kanavaros P, Manoussos O, Eliopoulos GD.Am J Gastroenterol. 1998 Jan;93(1):106-8. doi: 10.1111/j.1572-0241.1998.106_c.x.Am J Gastroenterol1998Link
Influence of hepatitis G virus infection on liver diseaseDiamantis ID, Kouroumalis E, Koulentaki M, Fasler-Kan E, Schmid PA, Hirsch HH, Bühler H, Gyr K, Battegay M.Eur J Clin Microbiol Infect Dis. 1997 Dec;16(12):916-9. doi: 10.1007/BF01700559.Eur J Clin Microbiol Infect Dis1997Link
Detection of hepatitis C virus in sera and genotyping according to the 5' non-coding regionTsopanomichalou M, Ergazaki M, Linardopoulos S, Kouroumalis E, Spandidos D.Oncol Rep. 1997 Nov-Dec;4(6):1171-4. doi: 10.3892/or.4.6.1171.Oncol Rep1997Link
Natural history of advanced hepatocellular carcinoma in Crete. Association with hepatitis C virusKouroumalis EA, Skordilis PG, Moschandrea J, Alexandrakis G, Charoulakis N, Tzardi M, Manousos ON.Eur J Gastroenterol Hepatol. 1997 Oct;9(10):981-8. doi: 10.1097/00042737-199710000-00011.Eur J Gastroenterol Hepatol1997Link
Autoimmune hemolytic anemia and positive Coombs test associated with ulcerative colitisGiannadaki E, Potamianos S, Roussomoustakaki M, Kyriakou D, Fragkiadakis N, Manousos ON.Am J Gastroenterol. 1997 Oct;92(10):1872-4.Am J Gastroenterol1997Link
Prevalence of hepatitis A, B, and C markers in school children of a rural area of Crete, GreeceLionis C, Frangoulis E, Koulentakis M, Biziagos E, Kouroumalis E.Eur J Epidemiol. 1997 Jun;13(4):417-20. doi: 10.1023/a:1007378608773.Eur J Epidemiol1997Link
Current prevalence of hepatitis A, B and C in a well-defined area in rural Crete, GreeceLionis C, Koulentaki M, Biziagos E, Kouroumalis E.J Viral Hepat. 1997 Jan;4(1):55-61. doi: 10.1046/j.1365-2893.1997.00125.x.J Viral Hepat1997Link
Ulcerative colitis is as common in Crete as in northern Europe: a 5-year prospective studyManousos ON, Giannadaki E, Mouzas IA, Tzardi M, Koutroubakis I, Skordilis P, Vassilakis S, Kouroumalis E, Vlachonikolis IG.Eur J Gastroenterol Hepatol. 1996 Sep;8(9):893-8.Eur J Gastroenterol Hepatol1996Link
A prospective epidemiologic study of Crohn's disease in Heraklion, Crete. Incidence over a 5-year periodManousos ON, Koutroubakis I, Potamianos S, Roussomoustakaki M, Gourtsoyiannis N, Vlachonikolis IG.Scand J Gastroenterol. 1996 Jun;31(6):599-603. doi: 10.3109/00365529609009134.Scand J Gastroenterol1996Link
Activating mutations in the k-ras gene in ulcerative-colitis and crohns-diseaseSpandidos D, Kiaris H, Lioudaki E, Manousos O.Oncol Rep. 1994 May;1(3):547-9. doi: 10.3892/or.1.3.547.Oncol Rep1994Link